1. Gaikwad S and Khan T. Phytochemistry and antibacterial activity of traditional medicinal plant Ziziphus rugosa LAM. Indian Drugs, 2023, 60 (03): 40-46. Scopus indexed
2. Tiwari D & Khan Tabassum, “Phytochemical screening, antioxidant and anti-inflammatory activity of Litsea ghatica stem bark” Indian Drugs, January 2023, 60 (01): 44-49, Scopus indexed
3. Singh Prabha; Waghambare P; Khan Tabassum & Omri A, Colorectal cancer management: strategies in drug delivery, Expert opinion on Drug Delivery, July
   2022, 19(6), 653-670(IF: 6.648) DOI: 10.1080/17425247.2022.2084531
4. Desai D; Patil S & Khan Tabassum, Functionalisation of polysaccharides versatile strategies and their applications, International Journal of Pharmaceutical Sciences & Research, July 2022, 13(7), 2587-2601. DOI: 10.13040/IJPSR.0975-8232.13(7).2587-01
5. Nadar S; Khan Tabassum & Omri A, Reemergence of monkeypox: prevention and Management, Expert Review of Anti-infective Therapy, September 2022, 22(11), 1425-1433(IF:5.854) DOI:10.1080/14787210.2022.2128763
6. Mansi Damani, Neha Desai, Bheeshma Pratap Singh, Raghumani Singh Ningthoujam, Munira Momin, Tabassum Khan, Synthesis of Hollow Gold Nanoparticles - Impact of Variables on Process Optimization,
   Journal of Pharmaceutical Sciences, 111 (10), 2022, 2907-2916 (ISSN 0022-3549) 
   DOI: https://doi.org/10.1016/j.xphs.2022.08.003 (IF = 3.784)
7. Jethva P, Momin M, Khan T, Omri A. Lanthanide-Doped Upconversion Luminescent Nanoparticles-Evolving Role in Bioimaging, Biosensing, and Drug Delivery. Materials (Basel). 2022 Mar 23;15(7):2374. doi: 10.3390/ma15072374 (IF = 3.748)
8. Nair A, Mallya R, Suvarna V, Khan TA, Momin M, Omri A. Nanoparticles-Attractive Carriers of Antimicrobial Essential Oils. Antibiotics (Basel). 2022 Jan 14;11(1):108. doi: 10.3390/antibiotics11010108. (IF = 5.222)
9. Vaibhavi Sonetha, Sharmi Majumdar, Soham Shah, Munira Momin, Tabassum Khan, Step-wise micro-fabrication techniques of microneedle arrays with applications in transdermal drug delivery, Journal of Drug Delivery Science and Technology, Volume 68, February 2022, 103119.
10. Nadar S & Khan Tabassum, Pyrimidine: An elite heterocyclic leitmotif in drug discovery-synthesis and biological activity Chemical Biology & Drug Design, November 2022, 100(6), 818-842(IF: 2.873) Review article. 10.1111/cbdd.14001
11. M Quadros, M Momin, G Verma, Implications of Synthesis Methodology on Physicochemical and Biological Properties of Hydroxyapatite, Handbook on Synthesis Strategies for Advanced Materials, 617-658: Book chapter.
12. Shaikh J; Patel Kavit & Khan Tabassum, Advances in pyrazole based scaffold as cyclin-dependent kinase 2 inhibitors for the treatment of cancer, Mini Reviews in  Medicinal Chemistry, 2022, 22(8), 1211-1229 (IF =3.862) DOI: 10.2174/1389557521666211027104957
13. Nadar S; Khan Tabassum; Patching S and Omri A, Development of Antibiofilm Therapeutics Strategies to Overcome Antimicrobial Drug Resistance. Microorganisms, January 2022, 10(2), 10020303(IF: 4.128) DOI:10.3390/microorganisms10020303
14. Gaikwad S & Khan Tabassum, A phyto pharmacological review on traditional medicinal plant ziziphus rugosa lam, International Journal of Pharmaceutical Sciences and Research, April  2022, 13(4), 1456-1462 (Scopus Indexed) Review article. 10.13040/IJPSR.0975-8232.13(4).1456-62
15. Suvarna Vasanti; Nair A; Mallya Rashmi; Khan Tabassum and Omri A, Antimicrobial nanomaterials for food packaging, Antibiotics, May 2022, 11(6), 1-31(IF: 4.6) DOI: https://doi.org/10.3390/antibiotics11060729
16. Jadeja K; Khambete M & Khan Tabassum, Phosphodiesterase (pde) inhibitors in alzheimer’s disease: role and current status, Indian Drugs, June 2022, 59(5), 7-16 (Scopus Indexed) Review article. https://doi.org/10.53879/id.59.05.12860
17. Chauhan C. and Khan Tabassum, Bionanotechnology: Emerging Applications of Bionanomaterials, chapter published Polymer-based bionanomaterials for biomedical applications, 2022, ISBN 978-0-12-823915-5, Elsevier.  https://www.sciencedirect.com/book/9780128239155/bionanotechnology-emerging-applications-of-bionanomaterials (Book Chapter)
18. Kapoor D. and Khan Tabassum, in the book titled, Antidiabetic plants for drug discovery: Pharmacology, secondary metabolite profiling and ingredients with insulin mimetic activity, chapter published, Antidiabetic Potential of Ficus benghalensis, ISBN 9781774910061, Apple Academic Press CRC Press Taylor & Francis Group. https://doi.org/10.1201/9781003282938 (Book chapter).
19. Khan Tabassum and Shaikh J in the book titled, Handbook of nanocelluloses, chapter published, Nanoparticle Decoration of Nanocellulose for Improved Performance, ISBN 978-3-030-62976-2, Springer. DOI: https://link.springer.com/referenceworkentry/10.1007/978-3-030-62976-2_22-1 (Book Chapter)
20. Atul Sherje, Shraddha Bodkhe, Mayuri Nikam, Tabassum Khan, Kavit Patel, Vasanti Suvarna, Current Insights on Clinical Efficacy of Roflumilast for Treatment of COPD, Asthma and ACOS, 2020, 88, 10696, (IF= 3.94) DOI: https://doi.org/10.1016/j.intimp.2020.106906 
21. Tabassum K, Mayuresh P, Munira M and Abdelwahab O, Macrophage Targeted Nanocarrier Delivery Systems in HIV Therapeutics, 2020, Expert Opinion on Drug Delivery, 2020, 17(7), 903-918, (IF= 4.84)  DOI: https://doi.org/10.1080/17425247.2020.1762565 
22. Omkar Sawant and Tabassum Khan, Management of periorbital hyperpigmentation-An overview of nature based agents and alternative approaches, 2020, Dermatologic Therapy, 2020, 33(4), 13717 (IF= 2.33) https://doi.org/10.1111/dth.13717.
23. T. Khan and H. Godbole, Ushirasava-Physicochemical standardization and quantitative estimation of some bioactives, International Journal of Pharmaceutical Sciences and Research, 2020; Vol. 11(5): 2332-2341. IF=0.83.
24. R. Singh and T. Khan, RP-HPLC method development and validation studies for the estimation of aspirin, clopidogrel bisulphate and rosuvastatin calcium in fixed dose combination capsules, International Journal of Pharmaceutical Sciences and Research, 2020; Vol. 11(5): 2366- 2373. IF=0.83
25. Mrunal Jadhav, Tabassum Khan, Chintan Bhavsar, Munira Momin & Abdelwahab Omri; Novel therapeutic approaches for targeting TB and HIV reservoirs prevailing in lungs, Expert Opinion on Drug Delivery, DOI: 10.1080/17425247.2019.1621287, May 2019, Impact Factor: 5.553
26. Kaksha Sankhe, Tabassum Khan, Chintan Bhavsar, Munira Momin & Abdelwahab Omri; Selective drug deposition in lungs through pulmonary drug delivery systems for effective management of drug resistant TB, Expert Opinion on Drug Delivery, May 2019, Taylor & Francis; IF=5.553.
27. Tabassum Khan, Sankalp Gharat, Mansai Chalke, Munira Momin; Development of simultaneous spectrophotometric method for quantification of resveratrol and folic acid in an orogel, International Journal of Pharmaceutical Sciences and Research, 2019; Vol. 10(4): 2035-2039; IF= 0.59.
28. Tabassum Khan, Amrita Date, Hardik Chavda & Krina Patel; Polysaccharides as potential anticancer agents—A review of their progress, Carbohydrate Polymers, 210, 2019, 412-428. Elsevier; IF= 5.158
29. Neha Desai, Munira Momin, Upasana Singh, Tabassum Khan, Atul Sherje; Analytical Method Development and Validation for Simultaneous Estimation of Curcumin and Cyclosporine by RP-HPLC, International Journal of Pharmacy and Pharmaceutical Sciences, Vol 11, Issue 2, 2019, 26-33.
30. Bhushan Dravyakar, Promod Khedekar, Tabassum Khan, Atul Sherje, Kavit Patel & Vasanti Suvarna; Design and Development of Novel 2-(Morpholinyl)-N-substituted Phenylquinazolin-4-amines as Selective COX-II Inhibitors, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 2019, 18, 1-22, Bentham.
31. Chintan Bhavsar, Tabassum Khan, Munira Momin & Abdelwahab Omri; Targeting tumor microenvironment to curb chemoresistance via novel drug delivery strategies”, Expert Opinion on Drug Delivery, Volume 15, Issue 7, 2018, p 641-663, Taylor Francis; IF= 5.553.
32. Sahil Butala, Kavit Patel, Tabassum Khan, Atul Sherje, Vasanti Suvarna & Bhushan Dravyakar; Mycobacterial siderophores: A review on chemistry and biology of siderophore and its potential as a target for tuberculosis, European Journal of Medicinal Chemistry, Volume 157, 5 September 2018, 783-790; Elsevier; IF = 4.816.
33. Megha Sarkar, Vasanti Suvarna, Tabassum Khan, Pramila Chaubey, Atul Sherje, Kavit Patel & Bhushan Dravyakar; Bone health and natural products-An insight, Frontiers in Pharmacology, 9, 981 September 2018; IF = 3.8.
34. Ekta Patel, Kavit Patel & Tabassum Khan; Imidazole and Pyrazole: Privileged Scaffolds for AntiInfective Activity, Mini Reviews in Organic Chemistry, 2018, 15(6); 459-475. IF= 0.722.
35. Kaksha Sankhe, Tabassum Khan, Atul Sherje, Vasanti Suvarna, Kavit Patel & Bhushan Dravyakar; DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents, Biomedicine & Pharmacotherapy 103 (2018) 923–938. IF- 3.457.
36. Tabassum Khan & Pranav Gurav; PhytoNanotechnology: Enhancing delivery of plant based anticancer drugs, Frontiers in Pharmacology–Ethnopharmacology, IF- 4.400.
37. Phytochemicals and PI3K Inhibitors in Cancer—An Insight, Frontiers in Pharmacology–Ethnopharmacology, December 2017, Volume 8, Article 916, IF- 4.400.
38. Tabassum Khan & Bhakti Sawant; Recent advances in delivery of antifungal agents for therapeutic management of candidiasis, Biomedicine and Pharmacotherapy, 96 (2017) 1478–1490, IF- 3.457.
39. Tabassum Khan & Sarvesh Rangnekar; Analytical method development and validation studies of ticagrelor tablets by RP-HPLC, International Journal of Applied Pharmaceutics, 9(04), 2017, 10-21.
40. Tabassum Khan & Richa Singh; Analytical method development and validation studies for the estimation of aspirin, clopidogrel bisulphate and rosuvastatin calcium in fixed dose combination capsule by UV spectroscopy, Indian Drugs, 54(06), 2017, 43-47.
41. Anjali Gohel, Rashmi Mallya & Tabassum Khan; Standardization of marketed Ayurvedic formulation, Balaguloochyadi kashayam- physicochemical, microbial evaluation and ephedrine content, Journal of Applied Pharmaceutical Science, Vol. 6 (12), 2016, p. 184-189, DOI: 10.7324/JAPS.2016.601226; ISSN 2231-3354.
42. Anti-osteoarthritic activity of Acacia nilotica pods in Wistar rats, Journal of Laboratory Animal Science Vol 4 Issue 1, August 2016, p 1-11.
43. Anish Chaurasia, Rashmi Mallya & Tabassum Khan; Novel Therapeutic Targets for Management of Type-2 Diabetes Mellitus, Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry; Vol. 16 Issue 1, 2016, p 18-30.
44. Anjali Gohel, Rashmi Mallya & Tabassum Khan; Standardization and HPTLC method development of marketed ayurvedic formulation-Balarishta, Int J Pharm Pharm Sci, Vol. 8, Issue 3, 2016, p 2010-2019.

1. Ali A; Nailwal N; Sawarkar Sujata & Doshi Gaurav, “Natural Immunomodulators for Infections and Other Diseases” 2022, 245-276, Book entitled as Natural Immunomodulators: Promising Therapy for Disease Management, ISBN: 978-981-5123-26-5 (Print) & ISBN: 978-981-5123-25-8 (Online)
2. Ansari A; Nailwal N; Sawarkar Sujata &Doshi Gaurav,” Marketing Strategy & Regulatory Perspective for Natural Immunomodulators” 2022, 325-368, Bentham Science Publishers Book entitled as Natural Immunomodulators: Promising Therapy for Disease Management, ISBN: 978-981-5123-26-5 (Print) & ISBN: 978-981-5123-25-8 (Online)
3. Prabhu P; Fernandes T; Damani M; ;Chaubey P ; Narayanan S and Sawarkar Sujata, Receptor specific ligand conjugated nanocarriers:an effective strategy for targeted therapy of tuberculosis. 
   Current Drug Delivery, 2022, 19(8), 830-845 (IF = 2.565) DOI: 10.2174/1567201819666211216141942.
4. 4. Udipi S; Joshi J; Singh G; Sawarkar Sujata; Phadke A; Prabhu Arati; Rastogi N & Vaidya A, Phytoactive as chelators of iron with the potential to mitigate its side effects and enhance iron absorption, International Journal of Pharmaceutical Science & Research, August 2022, 13(8), 3078-3102(Scopus Indexed) Review article. https://ijpsr.com/bft-article/phytoactive-as-chelators-of-iron-with-the-potential-to-mitigate-its-side-effects-and-enhance-iron-absorption/
5. Archana S. Pokkalath, Apurva Sawant, Sujata P. Sawarkar, Herbal medicine for ocular diseases: An age old therapy and its future perspective, Journal of Drug Delivery Science and Technology, 68, 2022,102979,
   ISSN 1773-2247 DOI: https://doi.org/10.1016/j.jddst.2021.102979 (IF = 5.062)
6. Sanjanwala D, Londhe V, Trivedi R, Bonde S, Sawarkar S, Kale V, Patravale V. Polysaccharide-based hydrogels for drug delivery and wound management: a review. Expert Opin Drug Deliv. 2022 Dec;19(12):1664-1695. DOI: 10.1080/17425247.2022.2152791 (IF = 8.129)
7. Tanna Vidhi; Sawarkar Sujata P.; Ravikumar Padmini, Exploring Nose to Brain Nano Delivery for Effective Management of Migraine, Current Drug Delivery, 20 (2), 2023, 144-157(14) DOI: https://doi.org/10.2174/1567201819666220401091632 (IF= 3.758)
8. S.P. Sawarkar, S.G. Deshpande, A.N. Bajaj, P.S. Soni, P. Pandit, V.S. Nikam,  Potential of low molecular weight natural polysaccharides for colon targeted formulation and its evaluation in human by Gamma Scintigraphy Journal of Pharmaceutical Investigationhttps://doi.org/10.1007/s40005-019-00447-x , ISSN:2093-5552
9. Sujata Sawarkar, Ashwini Ashtekar,Transdermal vitamin D supplementation—A potential vitamin D deficiency treatment, Journal of Cosmetic Dermatology, doi: 10.1111/jocd.13085, IF 1.311 
10. Krishna Baxi, Sujata Sawarkar, Munira Momin, Trinette Fernandes & Vainav Patel, Vaginal siRNA delivery: overview on novel delivery approaches , Drug  Drug Deliv. and Transl. Res., DOI 10.1007/s13346-020-00741-4 ISSN: ISSN 2190-393X   Journal homepage: https://www.springer.com/journal/13346 , Impact factor : 3.041.
11. Trinette Fernandes, Krishna Baxi, Sujata Sawarkar, Bruno Sarmento& José das Neves, Vaginal multipurpose prevention technologies: promising approaches for enhancing women’s sexual and reproductive health  
12. Expert Opinion on Drug Delivery, DOI: 10.1080/17425247.2020.1728251 ISSN: 1742-5247 (Print) 1744-7593 (Online) Journal homepage: https://www.tandfonline.com/loi/iedd20  Impact factor : 5.4 
13.  Pramila Chaubey, Munira Momin and Sujata Sawarkar , Significance of Ligand-Anchored Polymers for Drug Targeting in the Treatment of Colonic Disorders, Frontiers in Pharmacology Experimental Pharmacology and Drug Discovery Front. Pharmacol., 25 February 2020 | https://doi.org/10.3389/fphar.2019.01628  Impact factor: 3.845.
14. Vritika Kulwal,  Krishna Baxi, Sujata Sawarkar , Lokesh Bhat,  Colorectal Cancer Management by Herbal Drug-Based Nanocarriers: An Overview , Critical Reviews™ in Therapeutic Drug Carrier Systems, 37(1):65–?104 (2020) DOI: 10.1615/CritRevTherDrugCarrierSyst.2019030507  Impact factor : 2.9.
15. Manasiya M., Sawarkar S., and Bajaj A.,  Topical Vitamin A Delivery, Challenges and Overview of Novel Approaches, 6 INDIAN DRUGS 56 (11) INDIAN DRUGS 56 (11) November 2019 
16. Trinette Fernandes, Sujata Sawarkar, Chintan Bhavsar, Current And Novel Approaches For Control of Dental Biofilm, International Journal of Pharmaceutics, November 2017, Elsevier, ISSN:0378-5173, Impact Factor : 3.654 
17. Bhagyesh Pendse , Sujata Sawarkar, Vitamin B12 Deficiency And Novel Drug Delivery Strategies, European Journal of Biomedical and Pharmaceutical Sciences, ejbps, 2017, Volume 4, Issue 03, XX-XX, ISSN 2349-8870.
18. Heena Gada, Sujata Sawarkar, Osteoarthritis: Overview And Novel Treatment Approaches, European Journal of Biomedical and Pharmaceutical Sciences, ejbps, 2016, Volume 3, Issue 12, 71-81,  ejbps, 2016, Volume 3, Issue 12, 71-81.
19. Sujata Sawarkar, Nigar Sheikh,  Targeting Approaches for Effective Therapeutics of Bone Tuberculosis, Journal of Pharmaceutical Microbiology, Vol. 2 No. 2016, pg 1-13. 
20. Sujata Sawarkar, Apurva Kadam, Novel Treatment Approaches for Maintenance of Dental Hygiene, Pharma Times, March 2016 Vol 48, No. 03, ISSN 0031-6849
21. Sujata Sawarkar, Ruta Pandit, Ishra Khatri, Spices and condiments, safer option for treatment of hyperlipidemia, Indian Journal of Pharmaceutical and Biological Research,  2015; 3(3):24-34, ISSN: 2320-9267
22. S Pashte, S. Sawarkar. P. Ravikumar, In-Situ Ophthalmic Gel Forming Solution Of Moxifloxacin Hydrochloride For Sustained Ocular Delivery, International Journal of Pharmaceutical sciences and Research, March 2016; Vol. 7(3): 1192-1205., E-ISSN: 0975-8232; P-ISSN: 2320-5148
23.  S. Gupta, S. Sawarkar and P. Ravikumar, Solubility enhancement of poorly water soluble protease inhibitor, International Journal of Pharmaceutical sciences and Research, Vol. 7, Issue 1; January, 2016
24. S. Sawarkar, S.G.Deshpande, A.N. Bajaj, V. Nikam, Layman Summary of In vivo evaluation of 5-ASA colon specific tablets using experimental induced colitis rat animal model, December 2015.
25. S. Sawarkar, S.G.Deshpande, A.N. Bajaj, V. Nikam, In vivo evaluation of 5-ASA colon specific tablets using experimental induced colitis rat animal model, AAPS Pharmascitech, May 2015
26. S. Sawarkar S. and A. Kore , Biosimilars – Need of the Future, Indian Drugs, February 2014.
27. S. Sawarkar, T. Gursalkar, S. Deshpande, Comparative Assessment of Topical Formulations by performing trans membrane Diffusion and Permeation using Diffusion Cells, Indian Drugs, July 2013.
28. P. Soni, ; S. Sawarkar, S. Deshpande, A. Bajaj, Design of colon targeting drug delivery systems using natural polymeric carriers and their evaluation by Gamma Scintigraphy technique, World Journal of Nuclear Medicine; v. 3(suppl.1); Jan 2004; p. 57-58.
29. S. Sawarkar, S. Deshpande, Safety (Toxicity) Studies of Cosmetics, Soap, Toiletries and Detergent Review Annual, 2001.
30. Sujata Sawarkar S.G. Deshpande, Amrita Bajaj, Intra-arterial  and Intravascular Drug Delivery Systems, Chapter published in book Advances in Controlled  and Novel Drug Delivery.
31. S. Sawarkar, S. Deshpande, Colours used in Cosmetics Souvenir of Congress on Cosmetic Technologies.
32. Sujata Sawarkar, Amrita Bajaj, Optimisation of Extrusion – Spheronisation Pelletisation Technology, Indian Drugs, January 1999.

1. New Insights in Psoriasis Management using Herbal Drug Nanocarriers, Current Pharmaceutical Design 2024; 30, 32 (4): 2550-2561. (Impact Factor: 2.6)
2. Revolutionizing Infertility Management through Novel Peptide-based Targets, Current Protein & Peptide Science 2024, (25),9: 737-751. (Impact Factor: 1.9)
3. Epigenetic aging in major depressive disorder: Clocks, mechanisms and therapeutic perspectives, European Journal of Pharmacology, Volume 978, 2024,176757 (Impact factor: 4.2).
4. Zebrafish Experimental Animal Models for AD: A Comprehensive Review. Curr Rev Clin Exp Pharmacol. 2024; 19 (4):295-311. (Impact factor: 1.1).
5. Unraveling the Role of the Glycogen Synthase Kinase-3β, Bruton's Tyrosine Kinase, and Sphingosine 1 Phosphate Pathways in Multiple Sclerosis. Endocr Metab Immune Disord Drug Targets. 2024; 24 (10): 1131-1145. Jan 26. (Impact factor: 1.9).
6. Deciphering the Role of Peroxisome Proliferator-activated Receptor α and Phosphodiesterase Type 5 Targets in Alzheimer's Disease, CNS & Neurological Disorders - Drug Targets 2024; 23 (8):956-970. (Impact factor: 3.0).
7. Glutamate Receptors and C-ABL Inhibitors: A New Therapeutic Approach for Parkinson's Disease, Central Nervous System Agents in Medicinal Chemistry 2024; 24 (1): 22-24 (Scopus).
8. New Promising Routes in Peptic Ulcers: Toll-like Receptors and Semaphorins, Endocrine, Metabolic & Immune Disorders - Drug Targets 2024; 24 (8): 865-878.  (Impact factor: 1.9).
9. Enhancing Gastric Ulcer Management: Novel Insights from Terazosin-Pantoprazole Combination Therapy. Indian Drugs; 61 (01) January 2024: 77-85 [Scopus Indexed].
10. A Cross Talk on the Role of Contemporary Biomarkers in Depression. Biomarkers. 2024 Jan 23:1-25. (Impact factor: 2.6)
11. Terazosin produces an antidepressant-like effect in mice exposed to chronic unpredictable mild stress behavioral alteration, Neuroscience Letters, Volume 822, 2024, 137653. (Impact factor: 2.5)
12. Viral therapy for targeted drug delivery to cancers: Recent advances, clinical and regulatory perspectives,

Journal of Drug Delivery Science and Technology, Volume 92, 2024, 105365. (Impact factor: 5).

13. An Update on the Emerging Role of Wnt/β-catenin, SYK, PI3K/AKT, and GM-CSF Signaling Pathways in Rheumatoid Arthritis, Current Drug Targets 2023; 24 (17):1298-1316. (Impact factor: 3.2).
14.  Deciphering the Function of New Therapeutic Targets and Prospective Biomarkers in the Management of Psoriasis, Current Drug Targets 2023; 24 (16): 1224-1238. (Impact factor: 3.2).
15. Comparative anti-inflammatory studies on timolol maleate and diclofenac sodium in, in vitro and in vivo models by oral routes. Indian Drugs; 60 (09) September 2023: 100-107 [Scopus Indexed].
16. Behavioral and Neurological Effects of Edaravone and Noscapine in Albino Wistar Rats. Exp Aging Res. 2023 Aug 24:1-16. (Impact factor: 1.8).
17. Deciphering the Role of Pyroptosis Impact on Cardiovascular Diseases, Current Drug Targets 2023; 24 (15): 1166-1183. (Impact factor: 3.2).
18. An Update on the Pathways and Aspects of Epilepsy Treatment Targets, Current Signal Transduction Therapy 2023; 18 (3): e101023221992 :45-62. (Scopus)
19. Cross talk about the role of Neuropeptide Y in CNS disorders and diseases, Neuropeptides, 2023, 102 102388: 1-25. (Impact factor: 2.9).
20. A Review of Proposed Mechanisms in Rheumatoid Arthritis and Therapeutic Strategies for the Disease, Endocrine, Metabolic & Immune Disorders - Drug Targets 2024; 24 (3): 291-301. (Impact factor: 1.9).
21. Benefit of Betaine in Isoniazid-Rifampicin-Induced Hepatotoxicity in Rats. Iranian Journal of Toxicology. 2023; 17(4):62-70. [Scopus Indexed].
22. A Mini-review on Helicobacter pylori with Gastric Cancer and Available Treatments, Endocrine, Metabolic & Immune Disorders - Drug Targets 2024; 24 (3): 277-290 (Impact factor: 1.9).
23. An Update on Potential Antidepressants Derived from Marine Natural Products. Cent Nerv Syst Agents Med Chem. 2023;23(2):71-85[Scopus Indexed].
24. Mohite Rupali and Doshi Gaurav, Elucidation of the Role of the Epigenetic Regulatory Mechanisms of PI3K/Akt/mTOR Signaling Pathway in Human Malignancies, Current Cancer Drug Targets 2024; 24 (3): 231-244. (Impact factor: 3.0).
25. An Update on Autophagy as a Target in the Treatment of Alzheimer's Disease. Current Drug Targets. 2023 ;24(7):547-567. (Impact factor: 3.200).
26. Deciphering the role of metal and non-metals in the treatment of epilepsy. Neurochemistry international, Vol. 167 105536. 12 May. 2023. (Impact factor: 4.297).
27. The Experimental Animal Models in Psoriasis Research: A Comprehensive Review. Int Immunopharmacol. 2023 Feb 21; 117:109897. doi: 10.1016/j.intimp.2023.109897. (Impact factor: 5.714).
28. Metoclopramide as a Potential Antipsychotic Against Long-Term Methionine Exposure in Zebrafish. Zebrafish. 2023 Feb;20(1):19-27. doi: 10.1089/zeb.2022.0033. (Impact factor: 2.229)- Research paper
29. Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health. CNS Neurol Disord Drug Targets. September 2022; 22(7):1008-1030.  (Impact Factor: 2.824)
30. Update on Oxytocin, Phosphodiesterase, Neurokinin, Glycine as a Therapeutic Approach in the Treatment of Schizophrenia. CNS Neurol Disord Drug Targets. September 2022, 22(7): 994-1007. (Impact Factor: 2.824)
31. Exploring Cytokines as Potential Target in Peptic Ulcer Disease: A Systematic Update. Endocr Metab Immune Disord Drug Targets. 2023; 23(1): 21-34 (Impact Factor: 2.387)
32. Deciphering the Role of β-Lactamase Inhibitors, Membrane Permeabilizers and Efflux Pump Inhibitors as Emerging Targets in Antibiotic Resistance. Indian J Microbiol, 62, 524-530 (2022).  (Impact factor: 2.21)
33. An update on emerging immunological targets and their inhibitors in the treatment of psoriasis. Int Immunopharmacol. 2022 Oct 28;113(Pt A):109341. (Impact factor: 5.714)
34. Evaluation of Curcumin, Piperine, and Ferrous Sulphate Combination Potential in the Adjuvant-induced Arthritis Model in Male Wistar Rats. Pharmacog Res. 2022;14(4):1-9. (Research Paper)
35. An Update on Proficiency of Voltage-gated Ion Channel Blockers in the Treatment of Inflammation-associated Diseases, Current Drug Targets 2022; 23(14). 1290-1303. (Impact Factor: 2.937)
36. Importance of Exploring N-Methyl-D-Aspartate (NMDA) as a Future Perspective Target in Depression. CNS Neurol Disord Drug Targets, 21 (10): 1004-1016. (Impact Factor: 2.824)
37. An update on novel therapeutic intervention in Rheumatoid arthritis. Int Immunopharmacol. 2022 Aug; 109:108794. (Impact Factor: 5.719)
38. Emerging Role of Interleukins for the Assessment and Treatment of Liver Diseases, Endocrine, Metabolic & Immune Disorders - Drug Targets, 22 (4): 371- 382. (Impact Factor: 2.89)
39. Antidiabetic Activity of Caulerpa racemosa: Role of Proinflammatory Mediators, Oxidative Stress, and Other Biomarkers, Planta Medica International Open 2022; 9(01):e60-e71. (Research Paper)
40. Unraveling the Immunomodulatory Potential of Cyprinus carpio. Journal of Young Pharmacists, 2022; 14(2):160-164.
41. Role of intracellular signaling pathways and their inhibitors in the treatment of inflammation. Inflammpharmacology, 29(3):617-640 (Impact Factor: 4.473)
42. Ozone Therapy: A Paradox or Panacea in various ailments. International Journal of Pharmaceutical Sciences, 2021; Vol. 12(2): 754-759.
43. Increasing prevalence of patients with Schizophrenia in India, Journal of Hospital Pharmacy 16(1) Jan. to March., 2021 (Jan. Supplement Issue-C) Page-1 -8
44. Gas Chromatography-High-Resolution Mass Spectrometry Elucidation and in vitro Cell Line Studies (Sulforhodamine B) on Niosomal Gel of Benincasa hispida. Phcog Res 2020;12:342-51
45. Deciphering Role of Cytokines for Therapeutic Strategies against Rheumatoid Arthritis”, Current Drug Targets (2020) 22: 7, 803-815 (IF: 3.465)
46.  A Review on Molecular Mechanisms and Patents of Marine-derived Anti-thrombotic Agents”, Current Drug Targets (2020) 22: 3, 318-335. (IF: 3.465)
47. Evaluation of biological activity of derivatives of one, 3, 4 thiadiazole, 1, 3, 4-oxadiazole and 1, 2, 4- triazole in Endocrine, Metabolic & Immune Disorders - Drug Targets, (2021) 21: 5: 905-911. (Impact Factor: 2.895)
48. A Review on Emerging Drug Targets in Treatment of Schizophrenia”, Current Drug Targets (2020) 21: 1, 1593-1605. (IF: 3.465)
49. Critical Insight into the Attributes of Emerging Novel Coronavirus (COVID-19) in India and Across the World”, Coronaviruses (2020) 1:49-56. (Bentham Science New Journal)
50. Gas chromatography-mass spectrometry elucidation and antipsoriatic activity on developed herbal formulations from Carissa congesta, Catharanthus roseus, Annona squamosa and Polyalthia longifolia Plant Extracts in Pharmacognsoy Research,  April-  June 2020, 12 (2) :163-168.
51. Evaluation  of bioactivity of Cucurbita people L., Cucumis Melo L. and Cucumis sativus L.seed extracts.Indian Journal of Experimental Biology, 2019, 57 , 269-273(IF: 0.88)
52. Chemical constituents from Polyalthia longifolia seeds extract by gas Chromatography-Mass spectroscopy (GC-MS) studies, Research Journal of Pharmacy and Technology, 2018, 11 (6), 2489-2492. [ISSN: Print -0974-360X, H index: 8, SJR: 0.13]
53. Phytochemical Investigation of Essential Oils from Petroleum Ether Extract of Annona Squamosa Seeds By Gas Chromatography-Mass Spectroscopy, International Journal of Pharmacognosy and Phytochemical Research, 2018, 10 (5), 235-239. [ISSN: Print -0975-4873, H index: 10, SJR: 0.12].
54. Exploring Possible Anticancer Potential Of Some Plants Of Cucurbitaceae Family, Research & Reviews: Journal of Pharmacognsoy and Phytochemistry, 2018, 5 (1), 65-70. [e-ISSN: 2321-6182 p-ISSN: 2347-2332].
55. Gas Chromatography-Mass Spectroscopy studies on ethanolic extract of dried leaves of Catharanthus Roseus, Asian journal of Pharmaceutical and Clinical Research, 2018, 11 (6) 336-340. [ISSN: 0974-2441 (Print), 2455-3891 (Online), H index: 23, SJR: 0.22]
56. Quantification of rutin and quercetin by HPTLC/HPLC and in vitro immunomodulatory and anticancer activities of Capparis moonii fruits extracts International Journal of basic and Clinical Pharmacology, 2018, 7(1), 153-161. [ISSN (Online): 2319-2003, ISSN (Print): 2279-0780].
57. Anti-inflammatory and antibacterial potential of Carissa carandas and Carissa spinarum nanoemulsions, International Journal of Pharmaceutical Sciences and Research 2017, 8 (12) 5137-5145. [ISSN (Online): 0975-8232,ISSN (Print): 2320-5148, H index: 22, SJR: 0.15]
58. Chemical Characterization of Phytochemicals of Cucurbitaceae Family by Gas Chromatography – Mass Spectroscopy, Current Traditional Medicine 2017, 3 (3) 100-122. [ISSN (Online): 2215-0846, ISSN (Print): 2215-0838]
59. In vitro cytotoxicity Studies on Tabernaemontana divaricata Leaves Extracts by Sulforhodamine B Assay Method. , International Journal of Pharmaceutical Sciences Review and Research 2017, 45(1) 179-182. ISSN: 0976-044X, H index: 22, SJR: 0.15]
60. Phytochemical analysis of nuts of Semecarpus anacardium using gas chromatography-mass spectrometry and high performance thin layer chromatography ,International Journal of Green Pharmacy, 2017, 11 (1) S 100-108.[ISSN/P: 0973-8258, ISSN/E:1998-4103, H index: 16, SJR: 0.14]
61. Effect of Shodhana attenuates cytotoxicity of methanolic extract of Semecarpus anacardium nuts, Research Journal of Pharmacy and Technology, 2017, 10 (2) 567-574. [ISSN:  0974-3618 (Print), 0974-360 X (Online), H index: 8, SJR: 0.13]
62. Identification and quantification of Gamma-tocopherol in Cucurbita pepo, Cucumis melo and Cucumis sativus seeds extracts by high performance liquid chromatography, Journal of Pharmacognosy and Phytochemistry , 2017, 6 (2) 192-196. [ISSN:2349-8234 (Print), 2278-4136 (Online)]
63. Gas Chromatography - Mass Spectroscopy Studies on Cestrum nocturnum Macerated Methanolic Extract, Asian journal of Pharmaceutical and Clinical Research, 2017, 10 (3) 259-264. [ISSN: 0974-2441 (Print), 2455-3891 (Online), H index: 23, SJR: 0.22]
64.  Carissa congesta Wight and Benincasa hispida (Thunb.) Cogn. as Budding Immunomodulatory Targets, Indian Journal of Experimental Biology, 2016, 54 (10) 650-658 (IF: 1.156 as per Clarivate Analytics Impact Factor)
65. Revelation of β-sitosterol from Benincasa hispida Seeds, Carissa congesta Roots and Polyalthia longifolia Leaves by High Performance Liquid Chromatography, Pharmacognosy Journal, 2016, 8 (6), 610-613. (Indexed in Chemical Abstracts).[ISSN: Print -0975-3575, H index: 12, SJR: 0.18]
66. Pharmacognostic quantification of flavonoids by high performance thin layer chromatography and in vitro cell line study on developed herbal formulation from Cestrum nocturnum plant extract, International Journal of Green Pharmacy, 2016, 10 (3) 183-192. [ISSN: 0973-8258, H index: 16, SJR: 0.14]
67. Elucidation of Flavonoids from Carissa congesta, Polyalthia longifolia, and Benincasa hispida Plant Extracts by Hyphenated Technique of Liquid Chromatography-mass Spectroscopy, Pharmacognosy Research, 2016, 8 (4), 281-286. (ISSN: Print -0976-4836, Online - 0974-8490, H index: 21, SJR: 0.51]
68. Analytical Quantification, immunomodulatory and Sulforhodamine B assay studies on Albizia lebbeck Leaves Extracts, Pharmacognosy Journal, 2016, 8 (5), 476-482.[ISSN: Print -0975-3575, H index: 12, SJR: 0.18]
69. Phytochemical Investigation of Essential Oils from Ethanolic Extract of Polyalthia longifolia by Gas Chromatography-Mass Spectroscopy, International Journal of Pharmacognosy and Phytochemical Research, 2016, 8(6), 881-884. [ISSN: Print -0975-4873, H index: 10, SJR: 0.12]
70. Development and evaluation of herbal formulation from Polyalthia longifolia, Tabernaemontana alternifolia, Benincasa hispida plant extracts, Der Pharmacia Lettre, 2016, 8(5), 170-183. [ISSN: Print -0975-5071, H index: 23, SJR: 0.14]
71. Quantification of Quercetin and Rutin from Benincasa hispida Seeds and Carissa congesta Roots by High Performance Thin Layer Chromatography and High Performance Liquid Chromatography, Pharmacognosy Research, 2016, 8 (1), 37-42. [ISSN: Print -0976-4836, Online - 0974-8490, H index: 21, SJR: 0.51]
72. Structural Elucidation of Chemical Constituents from Benincasa hispida seeds and Carissa congesta roots by Gas Chromatography - Mass Spectroscopy, Pharmacognosy Research, 2015, 7 (3), 282-293 .[ISSN: Print -0976-4836, Online - 0974-8490, H index: 21, SJR: 0.51]
73. High Performance Thin Layer Chromatography and High Performance Liquid Chromatography Determination of Quercetin from Polyalthia longifolia leaves, Free Radicals and Antioxidants, 2015, 5 (2), 60-64. [ISSN: 2231-2536]
74. Elucidation of β-sitosterol from Benincasa hispida Seeds, Carissa congesta Roots and Polyalthia longifolia leaves by High Performance Thin Layer Chromatography, Pharmacognosy Journal, 2015, 7 (4), 221-227 .[ISSN: Print -0975-3575, H index: 12, SJR: 0.18]
75. In Vitro Cytotoxicity Studies on Carissa congesta, Polyalthia longifolia and Benincasa hispida extracts by Sulforhodamine B Assay Method, International Journal of Green Pharmacy, 2015, 9 (3) 157-161.[ISSN: 0973-8258, H index: 16, SJR: 0.14]
76. Identification of Ursolic Acid from Carissa congesta Roots by High Performance Thin Layer Chromatography and High Performance Liquid Chromatography, International Journal of Indigenous Medicinal Plants, 2015 48 (1), 1786-1788.[ISSN: 2051-4263]
77. Screening of Polyalthia longifolia Leaves as Potential Immunomodulatory Target, International Journal of Pharmacology, 2015, 11 (2), 106-113[ISSN: 1812-5700, 1811-7775, H index: 27, SJR:0.30]
78. Cold Extraction of Carissa congesta Wight Monitored by a Comparative Revision of HPLC and HPTLC, Pharmacognosy Communications, 2014, 4 (2), 29-33. [ISSN: 2249-0159 (Print) ; 2249-0167 (Online)]
79. Chromatographic Studies on Benincasa hispida (Thunb.) Cogn Seed Extract Scrutinized by HPLC and HPTLC, Pharmacognosy Journal, 2014, 6 (3), 42-48.[ISSN: Print -0975-3575, H index: 12, SJR:0.18]
80. Formulation, Pharmaceutical Properties, Chronopharmacology of Diclofenac Sodium Water-in-Oil-in-Water Emulsion by using Tail Immersion Method, World journal of Pharmaceutical Research, 2014, 3 (1), 749-758.[ISSN:2277-7105]
81. Development and Validation of Stability Indicating RP-HPLC Method for Simultaneous Determination of Telmisartan and Hydrochlorothiazide from their Combination Drug Product, Der Pharmacia Lettre, 2014, 5 (6), 127-134.[ISSN: Print -0975-5071, H index: 23, SJR: 0.14]
82. Solicitation of HPLC and HPTLC Techniques for Determination of Rutin from Polyalthia longifolia Thwaites, Pharmacognosy Research, 2014, 6 (3), 234-239.[ISSN: Print -0976-4836, Online - 0974-8490, H index: 21, SJR: 0.51]
83. Recent Advances and Management Appraisal for the Chemotherapy of AIDS, Pharmacophore, 2014, 5 (1), 1-23.[ISSN: 2229-5042]
84. Novel Techniques in Herbal Drug Delivery Systems, International Journal of Pharmaceutical Sciences Review & Research, 2014, 28 (2), 83-89. [ISSN: Print -2249-3379, H index: 22, SJR: 0.15]
85. Recent trends in Hard Gelatin Capsule Delivery System, Journal of Advanced Pharmacy Education & Research, 2014, 4 (2), 165-177.[ISSN: Print -2249-3379]
86. Rasayanas and Non-rasayanas Herbs: Future Immunodrug–Targets, Pharmacognosy reviews, 2013, 7 (14), 92-96. [ISSN: Print -0973-7847, Online - 0976-2787, H index: 30, SJR: 1.12]
87. Novel Antibiotics from Marine Sources, International Journal of Pharmaceutical Sciences and Nanotechnology, 2011, 4 (3), 1446-1461. [ISSN: 0974-3278]
88. Carbohydrate Vaccines - A burgeoning field of Glycomics, Journal of Applied Pharmaceutical Science, 2011, 1 (2), 17-22. [ISSN: 2231-3354, H index: 24, SJR: 0.24]
89. Evaluation of in-vitro antioxidant methods of Cassia auriculata, Der Pharmacia Lettre, 2011, 3 (3), 297-305. [ISSN: 0975-5071, H index: 23, SJR:0.14]
90. Pharmacognostical Standardization and Toxicity Profile of the Methanolic Leaf Extract of Plectranthus amboinicus (Lour) Spreng, Journal of Applied Pharmaceutical Science, 2011, 1 (2), 75-81.[ISSN: 2231-3354, H index: 24, SJR: 0.24]
91. Anti-inflammatory potential of Cassia auriculata flowers, Journal of Pharmaceutical Research and Clinical Practice, 2011, 1, 50-58. [ISSN: 2231-4237, Indexed in Ayush Research Portal]
92. Antiarthritic studies on Nyctanthes arbortristis and Maharasnadi ghan, Scholar's Research Library, Der Pharmacia Lettre, 2011, 3, 101-110. [ISSN: Print -0975-5071, H index: 23, SJR: 0.14]
93. Antibacterial potential of Cassia auriculata flowers, Journal of Microbiology and Biotechnology Research, 2011, 1 (3), 15-19. [ISSN:2231-3168]
94. Acute and Subacute Models of Inflammation of Nyctanthes arbortristis and Maharasnadi ghan, International Journal of Pharmacological Research, 2011, 1 (1), 14-24. [ISSN: 2277-3312]
95. Studies on the Prescriptions of Cardiovascular Units, Journal of Applied Pharmaceutical Science, 2011,1 (3), 128-131. [ISSN: 2231-3354, H index: 24, SJR: 0.24

BOOK CHAPTERS:

1. Namrata Nailwal, Nirav Bhatia, Aaliya Ali, Alveera Ansari, Radhika Raheja, Angel Godad and Gaurav Doshi, Chapter 4: Antioxidative agents obtained from marine-derived sources inn Book titled as Marine Antioxidants (Elsevier, Academic Press): 45-52, Total Pages of book: 532, Published: December 4, 2022, Paperback ISBN: 9780323950862 & eBook ISBN: 9780323950879
2. Gaurav M Doshi, Hemen S Ved, Ami P Thakkar, Nirav Y. Bhatia, Prachi M Pimple; Pharmacotherapy of Emerging Antiviral Agents, Frontiers in Clinical Drug Research: Anti-Infectives (2021) 8: 55. (Book Chapter- Bentham Publishers) ISSN: 2452-3208 (Print), ISSN: 2352-3212 (Online), ISBN: 978-981-5039-42-9 (Print) & ISBN: 978-981-5039-41-2 (Online)
3. Aaliya Liyakath Ali, Namrata Nailwal, Sujata Sawarkar and Gaurav Doshi published book chapter “Natural Immunomodulators for Infections and Other Diseases” 2022, 245-276, Bentham Science Publishers Book entitled as Natural Immunomodulators: Promising Therapy for Disease Management, ISBN: 978-981-5123-26-5 (Print) & ISBN: 978-981-5123-25-8 (Online)
4. Alveera Ansari, Namrata Nailwal, Sujata Sawarkar and Gaurav Doshi published book chapter “Chapter 10: Marketing Strategy & Regulatory Perspective for Natural Immunomodulators” 2022, 325-368, Bentham Science Publishers Book entitled as Natural Immunomodulators: Promising Therapy for Disease Management, ISBN: 978-981-5123-26-5 (Print) & ISBN: 978-981-5123-25-8 (Online)
5. Angel Godad, Alveera Ansari, Nirav Bhatia, Aaliya Ali, Sandip Zine, Gaurav Doshi, Chapter 20 - Drug nutraceutical interactions in Book titled as Industrial Application of Functional Foods, Ingredients and Nutraceuticals (Elsevier, Academic Press): Pages 663-723. Published on 17th August 2023, ISBN 9780128243121.
6. Swati Mittal, Sujata Sawarkar, Gaurav Doshi, Prachi Pimple, Jenny Shah, Turabali Bana, Chapter 21 - Pharmacokinetics and bioavailability of nutraceuticals in Book titled as Industrial Application of Functional Foods, Ingredients and Nutraceuticals, (Elsevier, Academic Press): Pages725-783. Published on 17th August 2023, ISBN 9780128243121.

BOOK PUBLICATION:

A Mini Guide LC-MS and GC-MS Techniques: A Tool for Phytoconstituents Evaluation of Plant Extracts DOI: https://doi.org/10.9734/mono/978-93-90149-30-8. [ISBN-13 (15) 978-93-90149-30-8]

1. Punmiya A, Prabhu A* "Structural fingerprinting of pleiotropic flavonoids for multifaceted Alzheimer’s disease" Neurochemistry International 2023; 163, 105486. IF= 4.297 
2. Borkar M., Prabhu, A, Kanugo A, Rupesh Gautam: Book chapter on "Pharmacophore modeling" in book titled, “Computational approaches in Drug Discovery, Development and Systems Pharmacology” ISBN: 9780323991377 (Elsevier) 
3. Udipi S A, Joshi J, Singh G, Sawarkar S, Phadke, A, Prabhu A, Rastogi, N,  Vaidya A B. Phytoactives as chelators of iron with potential to mitigate its side effects and enhance iron absorption. Int J Pharm Sci Res. 2022; 13 (8): 3078–102. Pise N, Prabhu A*, Raheja R and Dhala I, "Therapeutic Peptides: Unravelling Conformational Dynamics by Systematic Application of Biophysical Techniques” Current Protein & Peptide Science 2022; 23 (9), 619-641. IF= 3.272  
4. Illham Dhala, Tabassum Khan, Arati Prabhu. “Natural Chimeras of Existing Drugs for Alzheimer’s Disease: Expanding the Target Landscape” Indian Journal of Pharmaceutical Education and Research 55 (1), 2021, S29 – 47 (IF: 0.531)  
5. Kaksha Sankhe, Arati Prabhu, Tabassum Khan, “Design strategies, SAR, and mechanistic insight of Aurora kinase inhibitors in cancer” Chemical Biology and Drug Design (2021), 98(1), 73-93 (IF: 2.873)  
6. Book chapter on ‘Chimeric Conjugates for Alzheimer’s Disease’ by Illham Dhala, Tabassum Khan, Arati Prabhu in ‘Alzheimer’s Disease: Drug Discovery.’ Pp 165 - 180 Huang X (Editor). Exon Publications, Brisbane, Australia ISBN: 978-0-6450017-0-9; doi: https://doi.org/10.36255/exonpublications.alzheimersdisease.2020 
7. Jadhav M., Prabhu A* "Metallic and polymeric green nanoplatforms in oncology" J. Applied Microbiology 2022; 134, 1-19 (IF= 4.061)
8. Abstract titled “Punmiya A, Gharat R, Prabhu A. Development of Bioactive Molecules for the Treatment of Alzheimer’s Disease. Med Sci Forum. 2022;14(1):7. (MDPI Conference proceedings)  
9. Abstract titled “Pise NP, Prabhu A, Raheja R. Forced Degradation Studies on Agents of Therapeutic Interest. Med Sci Forum;14(1):22 (MDPI Conference proceedings)Pimpale Prachi; Singh Prabha; Prabhu Arati & Gupta S, Development and optimization of HP-β-CD inclusion complex-based fast orally disintegrating tablet of pitavastatin calcium, Journal of Pharmaceutical Innovation, 2022, 17,  993-1010 DOI: https://doi.org/10.1007/s12247-022-09661-x (IF= 2.538).
10. Pise N; Prabhu Arati; Raheja Radhika and Dhala I, Therapeutic Peptides: Unravelling Conformational Dynamics by Systematic Application of Biophysical Techniques, Current Protein & Peptide Science, 2022, 23(9), 619-641. DOI: 10.2174/1389203723666220908150054 (IF= 3.272).
11. Dixit G & Prabhu Arati, The pleiotropic peroxisome proliferator activated receptors: Regulation and therapeutics, Experimental & Molecular Pathology, 2022, 124, 104723. DOI: https://doi.org/10.1016/j.yexmp.2021.104723 (IF= 4.4.01).
12. Patel M & Prabhu Arati, Smart nanocomposite assemblies for multimodal cancer theranostics, International Journal of Pharmaceutics, 2022, 618, 1-15 DOI: https://doi.org/10.1016/j.ijpharm.2022.121697 (IF= 5.875).
13. Gharat R; Prabhu Arati & Khambete M, Potential of triazines in Alzheimer’s disease: a versatile scaffold, Archiv der Pharmazie, 2022, 355, 2100388. DOI: DOI: 10.1002/ardp.202100388  (IF= 3.751)
14. Zahara Khanjiwala, Anubha Khale, AratiPrabhu “Docking structurally similar analogues: Dealing with thefalse-positive” Journal of Molecular Graphics and Modelling 93 (2019) 107451
15. A Anantram, H Kundaikar, M Degani, APrabhu. “Molecular dynamic simulations on an inhibitor of anti-apoptotic Bcl-2proteins for insights into its interaction mechanism for anti-cancer activity”J Biomol Struct Dyn. Published online 10 December 2018, 2018, doi:10.1080/07391102.2018.1508371.
16. Arati Prabhu.” Molecular dynamicssimulations: A mechanistic probe for understanding antibacterial activity.”Int. J. Pharm. Chem. Anal. 2017 4 (3): 66 – 69
17. Dunkern T, Chavan S, Bankar, D, Patil,A, Kulkarni P, Kharkar P, Prabhu A, Goebel H, Rolser E, Burckhard-Boer W,Arumugam P, Makhija M. “Design, synthesis and biological evaluation of novelinosine 5’-monophosphate dehydrogenase (IMPDH) inhibitors.” J. Enzyme Inhib.Med. Chem. 2014 Jun;29(3):408-19
18. Dunkern T, Prabhu A, Kharkar PS, GoebelH, Rolser E, Burckhard-Boer W, Arumugam P, Makhija MT. “Virtual andexperimental high-throughput screening (HTS) in search of novel inosine5’-monophosphate dehydrogenase II (IMPDH II) inhibitors” J Comput Aided Mol Des11, 2012, 1277 – 92
19. Avdhoot D. Velankar , GianlucaQuintini, Arati Prabhu, Alexander Weber, Gundula Hunaeus, Britta Voland, MonikaWuest, Christian Orjeda, Dipak Harel, Shaji Varghese, Vikas Gore, Meenal Patil,Deepak Gayke, Matthias Herdemann, Isabelle Heit b,§, Andrea Zaliani .“Synthesis and biological evaluation of novel (4 or 5-aryl) pyrazolyl-indolesas inhibitors of interleukin-2 inducible T-cell kinase (ITK)” Bioorganic &Medicinal Chemistry 18 2010, 4547–4559
20. Jitendra Verma, Vijay Khedkar, AratiPrabhu, Santosh Khedkar, Alpeshkumar Malde and Evans Coutinho. “A comprehensiveanalysis of the thermodynamic events involved in ligand-receptor binding usingCoRIA and its variants” J Comput Aided Mol Des 22, 2008, 91 -104
21. Amarnath Chatterjee, P. M. KrishnaMohan, Arati Prabhu, Anindya Ghosh-Roy, Ramakrishna V. Hosur. “Equilibriumunfolding of DLC8 monomer by urea and guanidine hydrochloride: Distinctiveglobal and residue level features.”Biochimie 89(1), January 2007, 117 -134.
22. Arati Prabhu, Evans Coutinho, SudhaSrivastava. “The Amino-terminal domain of human signal transducers andactivators of transcription 1: Overexpression, purification andcharacterisation” J. Biosci. 30 (5), December 2005, 611 – 618.
23. ErrolMathias, Arati Prabhu, Evans Coutinho, Sudha Srivastava and Uma Halkar. “Thesolution structure of a cyclic analog of Neuropeptide Y with high affinity Y1receptor affinity by NMR, CD and MD simulations.” International Journal of PeptideResearch and Therapeutics Vol. 11, No. 2, June 2005, 143 – 152.
24.  AratiPrabhu, Alpesh Malde, Evans Coutinho, Sudha Srivastava. “Solution conformationof Substance P antagonists - [D-Arg1, D-Trp7,9, Leu11]- SP , [D-Arg1, D-Pro2,D-Trp7,9, Leu11]-SP and [D-Pro2, D-Trp7,9]-SP by CD, NMR and MDsimulations.”Peptides (26) 2005, 875 – 885.
25. AratiPrabhu and Evans Coutinho “Molecular Modeling in the Drug Industry” Souvenir ofthe 5th International Symposium on Innovations in Pharmaceutical Sciences andTechnology, Mumbai, 2003, pg. 29. (Non-peer reviewed article).
26. AratiChandraghatgi and H.P.Tipnis “Bioequivalence study of Famotidine formulationsin healthy human volunteers” Indian Drugs 28(2) 1990, 78 – 81. 

1. Rohit Jaiswal, Atul P. Sherje*, Recent advances in biopolymer-based smart hydrogel for wound healing, Journal of Drug Delivery Science and Technology, Volume 99, September 2024, 105990 (August 2024) (IF- 4.5) DOI: https://doi.org/10.1016/j.jddst.2024.105990.
2. Ritika Khivansara, Sandhya Jadhav, Maheshkumar Borkar, Atul Sherje*, A Concise Review on Analytical Methods for Determination of Nilotinib, Current Analytical Chemistry, 2023, 19, 513-530 (IF= 1.8) DOI: https://doi.org/10.2174/0115734110270070231012123849.
3. Maheshkumar R. Borkar, Kaushal Khade, Atul Sherje, A comprehensive review on structural attributes of biofilm inhibitors against potential targets, Journal of Molecular Structure, 1293, Dec. 2023, 136262 (IF= 3.8) DOI: https://doi.org/10.1016/j.molstruc.2023.136262.
4. Anuja Harugade, Atul P. Sherje*, Anil Pethe. Chitosan: A review on properties, biological activities and recent progress in biomedical applications, Reactive and Functional Polymers, Oct 2023, 191, 105634 [IF- 5.1]. DOI: https://doi.org/10.1016/j.reactfunctpolym.2023.105634
5. Anil Pethe, Arya Shanbhag, Atul Sherje, Surendra Agrawal. Formulation and evaluation of aspirin-loaded PLGA nanoparticles for ophthalmic use, Int J App Pharm, March 2023, 15 (2), 161-165.  DOI: https://dx.doi.org/10.22159/ijap.2023v15i2.46636.
6. Greeshma Surendran, Atul P. Sherje*, Biomedical Applications of Agar and its Composites: A Mini-Review. The Natural Products Journal, 13 (5), May 2023, 23- 30.
   Atul Sherje*, Sneha Dias, Development and validation of RP-HPLC method for determination of nortriptyline hydrochloride in bulk and dosage form, Indian Drugs 59 (08) august 2022, 49-52. https://doi.org/10.53879/id.59.08.11384.
7. Bhatia NY, Jalgaonkar MP, Hargude AB, Sherje Atul; Oza Manisha & Doshi Gaurav, Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health. CNS Neurological Disorder Drug Targets. August 2022(IF: 2.824) DOI:10.2174/1871527321666220822172039 Online ahead of print
8. Sherje Atul & Dias S, Development and validation of RP-HPLC method for determination of nortriptyline hydrochloride in bulk and dosage form Indian Drugs, August 2022, 75(08), 49-52. (Scopus Indexed) DOI: 10.53879/id.59.08.11384
9. Surendran G & Sherje Atul, Cellulose nanofibers and composites: An insight into basics and biomedical applications Journal of Drug Delivery Science & Technology September 2022, 75, 103601(IF:5.062) Review article. 
10. Mali P & Sherje Atul, Cellulose nanocrystals: fundamental and biomedical applications, Carbohydrate Polymers, January 2022, 275, 1-14(IF:9.381) Review article.   https://www.sciencedirect.com/science/article/abs/pii/S0144861721010559
11. Shah D, Sherje AP. Conspectus of Covid-19. Int J BotStud. July 2021;6(4):449–55.
12. Shetty K, Sherje AP. Nano intervention in topicaldelivery of corticosteroid for psoriasis and atopic dermatitis—a systematicreview. J Mater Sci Mater Med. July 2021; 32(8):88 (Impact factor- 3.896). DOI: 10.1007/s10856-021-06558-y
13. Pinky Yadav, Jigna Jain, Atul P. Sherje. Recent advancesin nanocarriers-based drug delivery for cancer therapeutics: A review. Reactiveand Functional Polymers. June 2021, 165, 104970 (IF = 3.975) DOI: https://doi.org/10.1016/j.reactfunctpolym.2021.104970
14. Shahbaz Rathor AS. Forced degradation studies oftizanidine hydrochloride and development of validated stability-indicating RP-HPLC method. Indian Drugs. April 2021;58(04):50–5.
15. Shaily Lalka MM and AS. Simultaneous estimation ofberberine hydrochloride and indomethacin for in vitro diffusion profile by UVSpectroscopy. Indian Drugs. Feb 2021;58(02):26–30
16. Varsha Daund, Siddhi Chalke, Atul P. Sherje*, Pravin P.Kale. ROS responsive mesoporous silica nanoparticles for smart drug delivery: Areview. Journal of Drug Delivery Science and Technology 64 (2021) 102599 (IF = 3.981) DOI: https://doi.org/10.1016/j.jddst.2021.102599
17. Shaily Lalkaa, Munira Momin, Atul Sherje. Simultaneousestimation of Berberine hydrochloride and Indomethacin for in vitro diffusion profileby UV spectroscopy, Indian Drugs, 58(2), 2021, 26-30.
18. Shradha Bodkhe, Mayuri Nikam,Atul P. Sherje, Tabassum Khan, Vasanti Suvarna, Kavit Patel. Current Insights on Clinical Efficacy of Roflumilast for Treatment of COPD, Asthma and ACOS. International Immunopharmacology (2020), 88, 106906. 
19. Sohini Bhattacharya, Atul P. Sherje; Development of Resveratrol and Green Tea Sunscreen Formulation for Combined Photoprotective and Antioxidant Properties. Journal of Drug Delivery Science and Technology (2020), 60, 102000.
20. AP Sherje, A Surve, P Shende. CDI cross-linked β-Cyclodextrin nanosponges of Paliperidone: Synthesis and physicochemical characterization, Journal of Materials Science: Materials in Medicine (2019), 30, 6, 74.
21. Bhushan R. Dravyakar*, Pramod B. Khedekar, Tabassum Khan, Atul P. Sherje, Kavit N. Patel, Vasanti Suvarna. Design and Development of Novel 2-(Morpholinyl)-N-substituted Phenylquinazolin-4-amines as Selective COX-II Inhibitor, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (2019), 18, 1-22.  
22. Jeevankala S. Tople, Atul Sherje, Rashmi Mallya. Analytical method development and validation for simultaneous determination of pyrantel pamoate and febantel in an oral dosage form by high-performance liquid chromatography (HPLC). International Journal of Pharmaceutical Sciences and Research (2019), 10, 4, 1747-1752. 
23. Neha Desai, Munira Momin, Upasana Singh, Tabassum Khan, Atul Sherje. Analytical method development and validation for simultaneous estimation of curcumin and cyclosporine by RP-HPLC. International Journal of Pharmacy and Pharmaceutical Sciences (2019), 11, 2, 26-33. 
24. Sherje A, Sonalkar A, Forced degradation studies of olmesartan medoxomil and chlorthalidone: development and validation of stability-indicating RP-HPLC method, Indian Drugs (2019), 56, 3, 39-45. 
25. Atul P. Sherje, Mrunal Jadhav, β-Cyclodextrin-based inclusion complexes and nanocomposites of rivaroxaban for solubility enhancement. Journal of Materials Science: Materials in Medicine (2018), 29, 186.
26. Kavitkumar Patel, Sahil Butala, Tabassum Khan, Vasanti Suvarna, Atul Sherje, Bhushan Dravyakar. Mycobacterial siderophore: A review on chemistry and biology of siderophore and its potential as a target for tuberculosis. European Journal of Medicinal Chemistry (2018), 157, 783-790. 
27. Atul P. Sherje, Mrunal Jadhav, Bhushan R. Dravyakar, Darshana Kadam. Dendrimers: A versatile nanocarrier for drug delivery and targeting. International Journal of Pharmaceutics (2018), 548, 1,  707-720. 
28. Tabassum Khan, Kaksha Sankhe, Vasanti Suvarna, Atul Sherje, Kavitkumar Patel, Bhushan Dravyakar. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents. Biomedicine and Pharmacotherapy (2018), 103,  923–938.
29. Atul P. Sherje, Forum Patel, Manikanta Murahari, Vasanti Suvarna, Kavitkumar Patel, Study on Effect of L-Arginine on Solubility and Dissolution of Zaltoprofen: Preparation and Characterization of Binary and Ternary Cyclodextrin Inclusion Complexes, Chemical Physics Letters (2018), 694, 120-128. 
30. Atul P. Sherje, Vaishali Londhe. Development and Evaluation of pH-Responsive Cyclodextrin-Based in situ Gel of Paliperidone for Intranasal Delivery. AAPS PharmSciTech (2018), 19, 1, 384–394. 
31. Atul P. Sherje, Bhushan R. Dravyakar, Darshana Kadam, Mrunal Jadhav, Cyclodextrin-based nanosponges: A critical review, Carbohydrate Polymers (2017), 173 37–49. 
32. Sherje Atul, Kulkarni Vaidehi, Murahari Manikanta, Nayak Usha, Bhat Pritesh, Suvarna Vasanti, Dravyakar Bhushan. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and auxiliary agents: Formulation characterization and Molecular modeling studies. Molecular Pharmaceutics (2017), 14, 1231−1242. 
33. Vasanti Suvarna, Apeksha Kajwe, Manikanta Murahari, Gurubasavaraj V. Pujar, Bharath kumar Inturi, Atul Sherje, Inclusion complexes of Nateglinide with HP-β-CD and L-arginine for solubility and dissolution enhancement: Preparation, characterization and molecular docking study. Journal of Pharmaceutical Innovation (2017), 12, 2, 168–181.
34. Sumit Vakani, Apeksha Kajwe, Vasanti Suvarna, Atul P. Sherje. Influence of Auxiliary Agents on Solubility and Dissolution Profile of Repaglinide with Cyclodextrin: Inclusion Complex Formation and its Solid-state Characterization, Journal of Inclusion Phenomenon and Macrocyclic chemistry (2015), 83, 3, 239-250. 
35. Atul P. Sherje, Vaishali Londhe. Ternary Inclusion Complex of Paliperidone with β-Cyclodextrin and Hydrophilic Polymer for Solubility and Dissolution Enhancement. Journal of Pharmaceutical Innovation (2015), 10, 4), 324-334.  
36. Sherje A, Londhe V. Inclusion Complexes of Hydroxypropyl-beta-Cyclodextrin and Paliperidone: Preparation and Characterization, Current Drug Discovery Technologies (Springer), 2014, 11, 271-278. 
37. Sherje AP, Kasture AV, Yeole PG, “Simultaneous spectrophotometric determination of lansoprazole and domperidone in capsule formulation”, Asian Journal of chemistry, 19 (5), 2007, 3612-3616. 
38. Atul P. Sherje,Vaishali Londhe. Stability Indicating HPLC method for determination of Paliperidone in Bulk. International Journal of PharmTech Research (2015), 8, 8, 157-163.
39. SP Dhat, SA Aphale,AP Sherje, JA Sakale, AV Vaidya, SD Vanshiv, Solubility enhancement of Satranidazole using solid dispersion technique, International Journal of Research in Pharmaceutical and Biomedical Sciences (2011), 2, 3, 1134-1138.
40. Sherje A.P., Desai KJ; Spectrophotometric determination of Rosiglitazone Maleate using Hydrotropic solubilization technique, Indian Journal of Pharmaceutical Sciences (2011), 73, 5, 579-582.
41. Sherje A.P., Chokshi J, Satam CA, Chaudhary D, Vanshiv SD, Spectrophothometric Determination of Nitazoxanide and Ofloxacin in Combined Dosage Form, Journal of Pharmacy Research (2010), 3, 1,72-74. 
42. Sherje AP, Tawade AP, Vyas M, Simultaneous Spectrophotometric Determination of Satranidazole and Ofloxacin in Combined Dosage Form, International Journal of PharmTech Research (2010), 2, 1, 511-514. 
43. Sherje AP, Rahigude A, Vanshiv SD, Warma S, Mixed Hydrotropy in Spectrophotometric Analysis of Nitazoxanide, International Journal of ChemTech Research (2010), 2, 4, 1966-1969. 
44. Sherje A.P., Yeole PG, Puranik MP, Momin MY, “In-vitro evaluation of Government hospital supplied and commercial brands of Paracetamol”, Indian Journal of Pharmaceutical Education (2005), 39, 1.
45. Sherje A.P., Kasture AV, Yeole PG, “Simultaneous quantitation of lansoprazole and domperidone in pharmaceutical formulations by liquid chromatography”, Journal of Pharmaceutical Research (2009), 8, 1, 52-55. 
46. Sherje A.P., Gujar KN, Bidkar AA, “Phytochemical and Pharmacological investigation of leaves of Calotropis procera Linn” Journal of Natural Remedies (2009), 9, 1, 79—84. 
47. Vanshiv Swapnila, Joshi Hemant, Sherje Atul, Aphale Sanjivani, Dhat Shalaka.  Gastroretentive Drug Delivery System: Review, Journal of Pharmacy Research (2009), 2, 12, 1879-1885. 
48. Sherje A.P., Kasture AV, Gujar KN, Yeole PG, “Simultaneous spectrophotometric determination of lansoprazole and domperidone in capsules” Indian Journal of Pharmaceutical Sciences (2008), 70, 1, 102-105.

List of Publications

1. Suvarna Vasanti; Bore B; Bhawar C; Mallya Rashmi, Complexation of phytochemicals with cyclodextrins and their derivatives-an update, Biomedicine & Pharmacotherapy March 2022, 149, 1-28. (IF: 6.529) Review article. https://doi.org/10.1016/j.biopha.2022.112862
2. Momin Munira; Khan Tabassum; Malliya Rashmi; Suvarna Vasanti; Omri A& Nair A, Nanoparticles—Attractive Carriers of Antimicrobial Essential Oils Antibiotics, January 2022, 11(1), 108 (IF: 4.63) Review article. 10.3390/antibiotics11010108
3. Mallya Rashmi & Bhitre M, Evaluation of antileukemic and antimalarial potential of zanthoxylum rhetsa dc (rutaceae), a well-known spice, Current Drug Therapy, June 2022, 17(3), 208-216 (0.175) Research article. 10.2174/0929866529666220426121117.
4. Bhawar C; Suvarna Vasanti & Mallya Rashmi, Simultaneous estimation of Naproxen and Famotidine by analytical Q absorption ratio method, International Journal of Pharmacy and Pharmaceutical Research. July 2022, 24(4), 264-273.Research article. https://ijppr.humanjournals.com/simultaneous-estimation-of-naproxen-and-famotidine-by-analytical-q-absorption-ratio-method/
5. Suvarna Vasanti; Nair A; Mallya Rashmi; Khan Tabassum and Omri A, Antimicrobial nanomaterials for food packaging, Antibiotics, May 2022, 11(6), 1-31(IF: 4.6) Review article. https://doi.org/10.3390/antibiotics11060729
6. Mundada S; Mallya Rashmi & Suvarna Vasanti, Formulation and evaluation of polyherbal vermifuge suspension, Science, Technology and Developments. 
7. 2022, 9(9), 394-402. Research article.
8. Mallya Rashmi ; Naik B and Momin Munira, Application of Herbs and Dietary Supplements in ADHD Management, CNS and Neurological Disorders Drug targets,  July 2022 (Scopus indexed) Online ahead of print. Review article 10.2174/1871527321666220720103923
9. Patil K & Mallya Rashmi, Genus zanthoxylum as sources of drugs for treatment of tropical parasitic diseases, Current Drug Discovery Technology, April 2022, 19(3), 1-13 (Scopus indexed) Review article. 10.2174/1570163819666220304203504
10. Rashmi Mallya, Milind Bhitre. Cytotoxic Activity and Initiation of Apoptosis via Intrinsic Pathway in Jurkat Cells by Leaf Extract of Zanthoxylum rhetsa DC [published online ahead of print, 2020 Aug 18.  Nutrition and  Cancer. 2020;1-12. doi:10.1080/01635581.2020.1808231 (Impact factor 2.3)
11. Gaurav, Rashmi Mallya and Ravi Yadav A novel validated RPHPLC method for the determination of related sustances  of Cinacalcet HCL API. European Journal  of Biomedical and Pharmeutical  Sciences. (2020),7(6),361-370
12. Pratik Terse, Rashmi Mallya. Formulation and Evaluation of Celecoxib loaded colon Targeted Microsponges. Asian Journal of. Research in  Pharmceutical  Sciences 2020; 10(2):73-78
13. Abna S, Rashmi M and Madhavi A. Development and characterization of anti-dandruff niosomal hair gel containing tea tree oil. Interntional  Journal of Pharmaceutical  Sciences & Research (2020),11(1): 91-93
14. Rashmi Mallya, Fehmina M, Akansha N and Milind B. Evaluation of Anthelmintic Potential of Leaves and Fruits of Zanthoxylum rhetsa Pharmacognosy Journal (2019),11,475-478
15. Jeevankala Tople, Atul Sherje and Rashmi Malya  Mallya R: Analytical method development and validation for simultaneous determination of Pyrantel pamoate and Febantel in an oral dosage form by High Performance Liquid Chromatography (HPLC). International  Journal of  Pharmaceutical Sciences and Research (2019),10(4),1747-52.
16. Mukesh C and Rashmi M. Phytochemical investigation and antibacterial activity of a medicinal plant. International Journal of Pharmaceutical and phytopharmacological research(2019), 9(4),53-8.
17. Mallya R and Bhitre, M. Pharmacognostic standardisation and chromatographic fingerprinting of leaves and fruits of Zanthoxylum rhetsa. International journal of pharmacy and pharmaceutical sciences.(2018),10(4),101-104
18. Abna Sreedhar, Madhavi Apte, Rashmi   Mallya. Pharmaceutical Waste Management Int J Pharm Sci Rev Res. (2018), 52(1),82-86
19. Mallya R and Bhitre, M. Pharmacognostic standardisation and chromatographic fingerprinting of leaves and fruits of Z anthoxylum rhetsa. International journal of Pharmacy and Pharmaceutical Sciences. (2018),10(4),101-104
20. Pratik T, Rashmi M, Importance of colon targeted drug delivery systems in herbal medicine. International Journal of Pharmaceutical Sciences and Research (2017),4513-4524.
21. Tabassum K, Anjali  S and Rashmi M. Standardisation and HPTLC method development of marketed ayurvedic formulation- Balaristha. International Journal of Pharmacy and Pharmaceutical Sciences. (2016), 8 (3),201-209
22. Tabassum K, Rashmi M and Anjali  S. Standardization of marketed Ayurvedic formulation, Balaguloochyadi kashayam- physicochemical, microbial evaluation and ephedrine content Journal of Applied Pharmaceutical Sciences.(2016), 6(12), 184-189
23. Dias L, Mallya R and Patani K: Development and Validation of New RP-HPLC Method for Estimation of Mephenesin and Ibuprofen. International Journal of Pharmaceutical  Sciences and Research. (2016), 7(12), 1000-07
24. Anishkumar C, Rashmi M and Tabassum K. Novel Therapeutic Targets for Management of Type-2 Diabetes Mellitus. Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry  (2016), 16(1), 16-30.
25. Monica Damle and Rashmi Mallya; Development and Evaluation of a Novel Delivery System Containing Phytophospholipid Complex for Skin Aging; AAPS PharmSciTech. (2016),17(3), 607-17.
26. Rashmi Mallya, Manisha Oza, Padmini Ravikumar and Madhavi Apte; Phytochemical and Pharmacological studies of stem bark of Cordia myxa Roxb extract; International journal of Pharmaceutical Research (2015) 7(4).
27. Jibin Joy Varghese  and Rashmi Mallya; Formulation development and Evaluation of antioxidant potential of Hesperidin Nanocrystals; World journal of Pharmaceutical research  (2015), 4(8), 1149-1170.
28. Alisha Pereira, Rashmi Mallya; Formulation and evaluation of a photoprotectant cream containing Phyllanthus emblica extractphospholipid Complex; Journal of Pharmacognosy and Phytochemistry (2015),4(2),232-240
29. Jignesh Khamkar, Kedar Prabhavalkar, Rashmi Mallya;  Development of a microemulsion gel comprising of Etodolac; World journal of pharmacy and Pharmaceutical Sciences (2015), 4(4).
30. Rashmi Mallya, Padmini Ravikumar;  Formulation and  evaluation of Natural hair colorants; International Journal of Pharmacy and Pharmaceutical Sciences (2015), 7(3), 347-349
31. Padmini Ravikumar and Rashmi Mallya; Development and evaluation of a polyherbal topical formulation;  JPR:BioMedRx: An International Journal (2013),1(7),637-640
32. Nirmala T. Vinita A, Ashok B, Rashmi M, Laxman S, Nancy P; Pharmacognostic and Phytochemical Investigation of Juglans regiaLinn; Pharmacognosy  Journal, (2011),3(25),39-43
33. Nirmala T. Vinita A, Ashok B, Rashmi M, Laxman S, Nancy P; Pharmacognostic and Phytochemical Evaluation of Citrus aurantifolia (Christm) Swingle PEEL; Pharmacognosy Journal (2011 ),3(26),70-76
34. N. D. Grampurohit, Padmini Ravikumar, Rashmi Mallya; Microemulsion for topical Use- A Review; Indian journal of Pharmaceutical Education and Research (2011), 45 (1), 100-107.
35. Annie S., Rashmi GP, and Malini S; Activity of Wedelia  calendulacea Less. in post-menopausal osteoporosis; Phytomedicine, (2006),13(1-2),43-48

1. Suvarna Vasanti; Sawant Niserga & Desai N, “A review on recent advances in mannose functionalized nanocarriers for targeted delivery in cancer and infective therapeutics” Critical Reviews™ in Therapeutic Drug Carrier Systems 2023, 40(2), pp. 43-82 (IF:4.889)
2. Suwarna Vasanti; Raut A, “ Analytical Methods For the Determination of Atypical Antipsychotic Drugs - An Update “,  Current Analytical Chemistry 2023, 19(2), 147 – 175(IF: 2.374)
3. Suvarna Vasanti; Bore B; Bhawar C; Mallya Rashmi, Complexation of phytochemicals with cyclodextrins and their derivatives-an update, Biomedicine & Pharmacotherapy March 2022, 149, 1-28 (IF: 6.529) DOI: https://doi.org/10.1016/j.biopha.2022.112862
4. Momin Munira; Khan Tabassum; Malliya Rashmi; Suvarna Vasanti; Omri A& Nair A, Nanoparticles—attractive carriers of antimicrobial essential oils, Antibiotics, 2022, 11(1), 108 (IF: 4.63) DOI: 10.3390/antibiotics11010108.
5. Bhawar C; Suvarna Vasanti & Mallya Rashmi, Simultaneous estimation of Naproxen and Famotidine by analytical Q absorption ratio method, International Journal of Pharmacy and Pharmaceutical Research. 2022, 24(4), 264-273.Research article https://ijppr.humanjournals.com/simultaneous-estimation-of-naproxen-and-famotidine-by-analytical-q-absorption-ratio-method/
6. Suvarna Vasanti; Nair A; Mallya Rashmi; Khan Tabassum and Omri A, Antimicrobial nanomaterials for food packaging, Antibiotics, May 2022, 11(6), 1-31(IF : 4.6) DOI: https://doi.org/10.3390/antibiotics11060729.
7. Mundada S; Mallya Rashmi & Suvarna Vasanti, Formulation and evaluation of polyherbal vermifuge suspension. Science, Technology and Development, September 2022, 9(9), 394-402. Research article
   Shinde R; Suvarna Vasanti & Abhyankar Arundhati, An insight into privileged scaffolds in tuberculosis: developmental aspects and implications in drug design. Indian Drugs, January 2022, 59(1), 7-22(IF: 0.126) DOI: https://doi.org/10.53879/id.59.01.13140
8. Chamriya R; Raheja Radhika; Suvarna Vasanti & Bhandare R, A critical review on phytopharmacology, spectral and computational analysis of phytoconstituents from Streblus asper Lour, Phytomedicine Plus, 2022, 2(1), 100177 (Scopus Indexed) DOI: https://doi.org/10.1016/j.phyplu.2021.100177
9. Suvarna Vasanti Deshmukh K & Murahari M, miRNA and antisense oligonucleotide-based α-synuclein targeting as disease-modifying therapeutics in Parkinson’s disease, Frontiers in Pharmacology, November 2022, 13,1034072 (IF: 5.988) DOI: 10.3389/fphar.2022.1034072.
10. Suvarna Vasanti; Sawant N & Desai N, A review on recent advances in mannose functionalized nanocarriers for targeted delivery in cancer and infective therapeutics. Critical Reviews™ in Therapeutic Drug Carrier Systems, December 2022, 40(2), 43-82.  (IF: 4.889) DOI:10.1615/CritRevTherDrugCarrierSyst.2022041853
11. Suvarna Vasanti & Chippa S, Current Overview of Cyclodextrin Inclusion Complexes of Volatile Oils and their Constituents Current Drug Delivery. 2022, 1-21 (IF: 3.758) Online ahead of print.  10.2174/1567201819666220630121939
12. Suvarna Vasanti; Gujar P; Murahari M; Sharma D & Chamariya R, Supramolecular ternary inclusion complexes of irbesartan with hydroxypropyl-beta-cyclodextrin. Journal of Drug Delivery Science and Technology, January 2022, 67, 1-11(3.981) DOI: https://doi.org/10.1016/j.jddst.2021.102964
13. Shinde R and Suvarna Vasanti, Fatty Acid Biosynthesis: An Updated Review on KAS Inhibitors, Current Drug Discovery Technologies, February 2022, 19(2), 1-15. DOI: 10.2174/1570163819666220111113032
14. Chamariya R& Suvarna Vasanti, Role of KSP inhibitors as anti-cancer an update
    Anti-cancer Agents in Medicinal Chemistry, April 2022, 22(14), 2517-2538(2.505) DOI:10.2174/1871520622666220119093105.
15. Murahari M, Singh V, Chaubey P, Suvarna V*. A Critical Review on Anticancer Mechanisms of Natural Flavonoid Puerarin. Anti-cancer Agents in Medicinal Chemistry. Volume 20 , Issue 6 , 2020, p-678 - 686. (Bentham publications)
16. Adishri Raut, Dhvani Sharma & Vasanti Suvarna (2020), A Status Update on Pharmaceutical Analytical Methods of Aminoglycoside Antibiotic: Amikacin, Critical Reviews in Analytical Chemistry, DOI: 10.1080/10408347.2020.1803042 (Taylor francis publications)
17. Suvarna V, Singh V, Murahari M. Current overview on the clinical update of Bcl-2 anti-apoptotic inhibitors for cancer therapy. European Journal of Pharmacology. 2019 Sep 5:172655.
18. Suvarna, V., Sarkar, M., Chaubey, P., Khan, T., Sherje, A., Patel, K., & Dravyakar, B. (2018). Bone Health and Natural Products- An Insight. Frontiers in pharmacology, 9, 981. (Frontiers publications)
19. Suvarna, Vasanti, Manikanta Murahari, Tabassum Khan, Pramila Chaubey, and Preeti Sangave. "Phytochemicals and PI3K Inhibitors in Cancer—An Insight." Frontiers in pharmacology 8 (2017 (Frontiers publications).
20. Suvarna, Vasanti, Siddhata Thorat, Usha Nayak, Atul Sherje, and Manikanta Murahari. "Host-guest interaction study of Efavirenz with hydroxypropyl-β-cyclodextrin and l-arginine by computational simulation studies: Preparation and characterization of supramolecular complexes." Journal of Molecular Liquids 259 (2018): 55-64. (Elsevier publications)
21. Suvarna, Vasanti M., and Preeti C. Sangave. "HPLC Estimation, Ex vivo Everted Sac Permeability and In Vivo Pharmacokinetic Studies of Darunavir." Journal of chromatographic science (2018).(Oxford press publications)
22. Patel, K., Butala, S., Khan, T., Suvarna, V., Sherje, A., & Dravyakar, B. (2018). Mycobacterial siderophore: A review on chemistry and biology of siderophore and its potential as a target for tuberculosis. European journal of medicinal chemistry.(Elsevier  publications)
23. Dravyakar, B. R., Khedekar, P. B., Khan, T., Sherje, A. P., Patel, K. N., & Suvarna, V. (2018). Design and Development of Novel 2-(Morpholinyl)-N-substituted Phenylquinazolin-4-amines as Selective COX-II inhibitor. Anti-inflammatory & anti-allergy agents in medicinal chemistry. (Bentham publications).
24. Tabassum Khan, Kaksha Sankhe, Vasanti Suvarna, Atul Sherje, Kavitkumar Patel, Bhushan Dravyakar. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents. Biomedicine & Pharmacotherapy 103 (2018) 923–938. (Elsevier publications)
25. Sherje, Atul P., Manikanta Murahari, Vasanti Suvarna, and Kavitkumar Patel. "Study on effect of L-arginine on solubility and dissolution of Zaltoprofen: Preparation and characterization of binary and ternary cyclodextrin inclusion complexes." Chemical Physics Letters (2018).(Elsevier publications)
26. Chaubey, Pramila, Brahmeshwar Mishra, Shyam Lal Mudavath, Ravi R. Patel, Sundeep Chaurasia, Shyam Sundar, Vasanti Suvarna, and Marvis Monteiro. "Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani." International journal of biological macromolecules (2018). (Elsevier publications).
27. Parinaz F. Elavia *, Vasanti Suvarna, A review on applications of nanotechnology in cosmetics, Int. Res. J. Pharm. 2018, 9 (4)
28. Suvarna V, Gujar P, Murahari M. Complexation of Phytochemicals with Cyclodextrin derivatives – An Insight , Biomedicine & Pharmaco- therapy.  2017 Feb 12; 88:1122-1144.(Elsevier publications.
29. Vasanti Suvarna & Apeksha Kajwe & Manikanta Murahari & Guru basavaraj V. Pujar & Bharath Kumar Inturi & Atul P. Sherje. Inclusion complexes of Nateglinide with HP-β-CD and L-arginine for solubility and dissolution enhancement: Preparation, characterization and molecular docking study Journal of Pharmaceutical innovation. June 2017, Volume 12, Issue 2, pp 168–181.(Springer publications)
30. Sherje AP, Kulkarni V, Murahari M, Nayak UY, Bhat P, Suvarna V, Dravyakar B. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and auxiliary agents: Formulation characterization and Molecular modeling studies, Molecular pharmaceutics,  2017, 14 (4), pp 1231–1242 (American chemical society publications)
31. Vasanti Suvarna, Utkarsha Paghadre, Anila Kadu, Manisha Oza "Development and characterization of solid self-emulsifying drug delivery system containing nateglinide" Asian Journal of Pharmaceutics.  2017 Mar 21;11(01).
32. Yunus Y. Khan, Vasanti Suvarna, Liposomes containing phytochemicals for cancer treatment-an update, International Journal of Current Pharmaceutical Research,Vol 9, Issue 1, 2017.
33. Suvarna, V. M., & Sangave, P. C. (2017). Development and validation of stability indicating RP-HPLC method for tenofovir solid lipid nanoparticles. International Journal of Pharmaceutical Sciences and Research, 8(2), 658-666.
34. Sumit S. Vakani,  Apeksha Kajwe, Vasanti Suvarna,  Atul P. Sherje, Influence of auxiliary agents on solubility and dissolution profile of repaglinide with hydroxypropyl-b-cyclodextrin: inclusion complex formation and its solid-state characterization. J Incl Phenom Macrocycl Chem (2015) 83:239–250.
35. Mohammed Sajid, Utkarsha Pagdhare and Vasanti Suvarna, Pharmacological evaluation and development of an antiulcer polyherbal formulation. World journal of pharmacy and pharmaceutical sciences Vol 4, Issue 05, 2015.
36. Kadam N. R. and Suvarna V, Microspheres: a brief review, Asian Journal of Biomedical and Pharmaceutical Sciences, 5(47), 2015, 13-19.
37. Lalit Rathod, Vasanti Suvarna and Neha k. Shinde, Development and validation of a stability indicating RP-HPLC method for simultaneous determination of acetylcysteine and cefixime in pharmaceutical formulation. IJPSR (2015), vol. 6, issue 11.
38. Vasanti S, Sulabha S, Aabha C. “Bioceramics”,  Journal of Pharmacy and research, Vol 2, No 10 (2009).
39. Suvarna Vasanti,  “Evaluation of antimicrobial activity of plant extracts” IJPSR, 2015; Vol. 6(4): 1547-1552
40. Vasanti S, Preeti S. Paclitaxel Nanoparticles - An Approach to Improve the Bioavailability  Int. J. Pharm. Sci. Rev. Res., 27(1) , July August 2014, 200-208.
41. Vasanti S, In-Vitro Cytotoxic Activity of Methanolic Extract of Embelia tsjeriam Cottam, against Human Breast and Colon Cancer Cell Lines.  Research Journal of Pharmaceutical, Biological and Chemical Sciences. 5(5), September - October 2014, 131.
42. Vasanti S, Shrutika P “Antifungal activity of selected plant extracts against human fungal pathogens” Journal of Herbal medicine and toxicology, 3(2) 151-153, (2009).
43. Vasanti S, Shrutika P, N.D Grampurohit “Evaluation of Antibacterial and Antifungal Activities Zingiber Cassumunar Roxb.” Asian journal of microbiology biotechnology & environmental sciences, 2008(3).
44. Vasanti S, Shrutika P “Antimicrobial activity of clove essential oil against    clinical dental isolates" Asian journal of microbiology biotechnology & environmental sciences. Vol. 11, No.(1), 2009: 137-138.
45. Vasanti S, “Synthesis of N-acyl heterocycles using conventional and microwave-assisted dry media technique” Journal of Pharmacy and research. October 2008 (1), Issue 2, Page no.240-.244.
46. Vasanti S, Sulabha S Impurity profile- A review .Drug Invention Today 2009, 1(2),81-88

List of Piblications

1. Parmar D & Apte Madhavi, Evaluation of seeds an Indian sacred plant Aegle marmelos for their antioxidant and cytotoxic potential. International Journal of Pharmaceutical Sciences and Research.  August 2022, 13(8), 3261-3274. DOI: 10.13040/IJPSR.0975-8232.     
2. Parmar D, Apte M. Angiopoietin inhibitors: A review on targeting tumor angiogenesis. Eur J Pharmacol. 2021 May 15;899:174021. doi: 10.1016/j.ejphar.2021.174021. Epub 2021 Mar 16. PMID: 33741382.
3. Sreedhar A., Mallya R., Apte M., Development and Characterization of anti-dandruff niosomal hair gel containing tee tree oil, IJPSR; 2020;11 (1): 91-103.
4. Ghongade Govind, Apte Madhavi, Review of herbal drug formulations and its evolutions; Mintage journal of pharmaceutical and medical sciences; 2019; 8 (1): 1-5.
5. Apte Madhavi, Dr. Bhitre Milind, The fingerprinting of extracts of flowers, leaves, bark, and seeds of Indian dhak tree, Butea monosperma by HPTLC technique.  IOSR Journal of Pharmacy; 8(12) December 2018. 
6.  Sreedhar A., Apte M., Mallya R., Pharmaceutical Waste Management International Journal of Pharmaceutical Sciences Review and Research Int J Pharm Sci Rev Res, Volume 52, Issue 1, September - October 2018.
7. Kadu Anila ,Apte Madhavi et al Phytosome: A Novel Approach to Enhance the Bioavailability of Phytoconstituent, Asian Journal of Pharmaceutics; 11(2)(2017): S453-S461.
8. Madhavi Apte, Bhitre M et al Comparative anti-angiogenesis activity of extracts of various parts of Indian dhak tree belonging to family Fabaceae, Medicinal and Aromatic Plants ; 6(5):19 ,2017.DOI: 10.4172/2167-0412-C1-011 
9.  Patel Shefali, Apte Madhavi, A Review on Significances of Impurity Profiling, Research Journal of Pharmaceutical Dosage Forms and Technology, 2016, 8(1):31-36.
10.  Lad Snehbrabha Lad, Apte Madhavi, Calcium Phosphate Cement – A drug novel drug delivery system; "International Journal of Pharmaceutical Research" (2015), 7 (3).
11. Mallya Rashmi, Oza Manisha, Ravikumar Padmini, Apte Madhavi,  Phytochemical and pharmacological studies of stem bark of Cordia myxa Roxb extract; "International Journal of Pharmaceutical Research" (2015), 7 (3). 
12. Apte Madhavi, An overview of Butea monosperma (Flame of Forest); WJPPS (2014 ), vol 3(1):307-319.
13. Apte Madhavi, Pharmacognostic and Phytochemical evaluation of the flowers of Butea monosperma (Flame of Forest); International Journal of Pharmacognosy and Phytochemistry (2014), 6(1):11-17.

List of Publications

1. Fuloria N; Raheja Radhika; Shah K; Oza Manisha; Kulkarni Y; Subramaniyan V; Sekar M and Fuloria S, Biological activities of meroterpenoids isolated from different sources, Frontiers in Pharmacology, September 2022, 1-36 (IF: 5.988) Review article. 10.3389/fphar.2022.830103.
2. Parmar U; Jalgaonkar  M;   Kulkarni   Y &  Oza Manisha, Autophagy nutrient sensing pathways in diabetic complications, Pharmacological Research, October 2022, 184, 106408. (IF: 10.334) Review article. https://doi.org/10.1016/j.phrs.2022.106408.  
3. Bhatia NY, Jalgaonkar MP, Hargude AB, Sherje Atul; Oza Manisha & Doshi Gaurav, Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health, CNS Neurological Disorder Drug Targets.  January 2022(IF: 2.824) Review article. Ahead of print. 10.2174/1871527321666220822172039.  
4. Jalgaonkar M; Parmar U; Kulkarni Y & Oza Manisha, SIRT1-FOXOs activity regulates diabetic complications, Pharmacological Research, IF: 7.85) Review article. https://doi.org/10.1016/j.phrs.2021.106014
5. Oza Manisha & Kulkarni YA, Biochanin A attenuates cardiomyopathy in type 2 diabetic rats by increasing SIRT 1 expression and reducing oxidative stress, Chemistry and Biodiversity, 2022, 19(3), 202100591(IF:2.408) Research article. 10.1002/cbdv.202100591
6. Shah KH, and Oza, MJ. Comprehensive Review of Bioactive and Molecular Aspects of Moringa Oleifera Lam. Food review international. 5th Oct. 2020. (Impact factor -4.113) 
7. Oza, MJ, & Kulkarni, YA.  Formononetin Ameliorates Diabetic Neuropathy by Increasing Expression of SIRT1 and NGF. Chemistry and biodiversity. 2020.17 (6),1-13  (Impact factor -2.039) 
8. Oza, MJ, & Kulkarni, YA.Trifolium pratense (Red Clover) Improve SIRT1 Expression and Glycogen Content in High Fat Diet-Streptozotocin Induced Type 2 Diabetes in Rats. Chemistry and biodiversity.2020.17 (4), 1-14 (Impact factor -1.44) 
9.  Oza, MJ, & Kulkarni, YA. Formononetin alleviates diabetic cardiomyopathy by inhibiting oxidative stress and upregulating SIRT1 in rats. Asian pacific journal of tropical biomedicine.2020. 10 (6), 254-262. (Impact factor -1.903) 
10. Sankrityayan H, Oza MJ, Kulkarni YA, Mulay SR, Gaikwad AB. ER stress response mediates diabetic microvascular complications. Drug Discov Today. 2019. pii: S1359-6446(19)30314-9. (Impact Factor: 6.88)  
11. Oza MJ and Kulkarni YA. Formononetin attenuates kidney damage in type 2 diabetic rats. Life sciences.2019. 219, 109-121. (Impact Factor: 3.234) 
12. Oza MJ and Kulkarni YA. A novel contribution to quality standards of Trifolium pratense L., A dietary supplement. Indian Journal of Natural Products and Resources (IJNPR).2018. 9 (4), 311-330. 
13. Oza MJ and Kulkarni YA. Biochanin A improves insulin sensitivity and controls hyperglycemia in type 2 diabetes. Biomedicine & Pharmacotherapy.2018. 107, 1119-1127. (Impact Factor: 3.457) 
14. Oza MJ and Kulkarni YA. Formononetin Treatment in Type 2 Diabetic Rats Reduces Insulin Resistance and Hyperglycemia. Frontiers in Pharmacology.2018. 9, 739.  (Impact Factor: 3.804)
15. Gupta A, Shah K, Oza MJ and Behl T. Reactivation of p53 gene by MDM2 inhibitors: A novel therapy for cancer treatment. Biomedicine & Pharmacotherapy.2018. 109, 484-492. (Impact Factor: 3.457) 
16. Oza MJ and Kulkarni YA. Traditional uses, phytochemistry and pharmacology of the medicinal species of the genus Cordia (Boraginaceae). Journal of Pharmacy and Pharmacology, 2017.69(7):755-789. (Impact Factor: 2.405) 
17. Oza MJ and Kulkarni YA. Phytochemicals and complications in type 2 diabetes- an update. IJPSR. 2016; Vol. 7(1): 14-24. 
18. Kambli L, Bhatt LK, Oza MJ, Prabhavalkar K. Novel therapeutic targets for epilepsy intervention. Seizure.2017. 51, 27-34. (Impact Factor: 2.83)   
19. Bhounsule AS, Bhatt LK, Prabhavalkar KS, Oza MJ. Cyclin Dependent Kinase 5: A novel avenue for alzheimer’s disease. Brain Research Bulletin.2017. 132, 28-38.  (Impact Factor: 3.44) 
20. Prajapati MS, Patel JB, Modi K, Shah MB. Leucas aspera: A review. Pharmacognosy reviews.2010. 4(7), 85.
21. Mallya R, Oza MJ, Ravikumar P, Apte M. Phytochemical and pharmacological studies of stem bark of Cordia myxa extract. International Journal of Pharmaceutical Research.2015. 7(3).  
22. Prajapati MS, Shah MB, Saluja AK, Shah UD, Shah SK. Research Article Antiasthmatic Activity of Methanolic Extract of Sphaeranthus indicus. International Journal of Pharmacognosy and Phytochemical Research.2010. 2(3): 15-19.

1. Meenal Rane*, Riddhi Ahuja, Urvashi Parmar, Mohnishh Balsara, Priyanka Bafna. Overview on scope and advancement in regenerative medicine. International Journal of Health sciences. https://doi.org/10.53730/ijhs.v6nS6.11252,Page.no.6676-6689,Scopus Indexed Issn.No. 6676-6978 .
2. Purva V, Meenal M Rane*.Herbal nanocosmecuticals: A review on cosmeceutical innovation Journal of Cosmetic Dermatology. 2022Nov;21(11):5464-5483. doi: 10.1111/jocd.15238. Epub 2022 Aug 8. 
3. Meenal Rane, Urvashi Parmar, Pankaj Paradia, Riddhi Ahuja. Review On Role Of Nutraceuticals In Bone Health.International Journal of Biolofy,Pharmacy and Allied sciences –UGC Approved journal indexed in Web of sciences, https://doi.org/10.31032/IJBPAS/2021/10.12.1027, 10(12): 290-310 published online,December2021.
4. Meenal M Rane, Riddhi Ahuja .Lipid Polymer-Based Bio-Inspired Drug Delivery System. International Journal of Pharmaceutical Sciences and Research, January2022. E-ISSN: 0975-8232; P-ISSN: 2320-5148; IJPSR, 2022; Vol. 13(1):101-117;DOI:10.13040/IJPSR.0975-8232.13(1).101-117; DOIlink: http://dx.doi.org/10.13040/IJPSR.0975-8232.13(1).101-17.
5. Madhura Mestry, Meenal Rane*, Amrita Bajaj. Commiphora mukul and Quercetin Loaded Liposphere Gel:Potential Treatment for Psoriasis. Indian Journal of Pharmaceutical Education and Research. Jul-Sep, 2020; 54(3).(Clarivate Analytics 2019:.425).
6. Meenal M Rane, Amrita Bajaj, Kapil Waghela. Development of Novel Topical Formulations forAnti-aging Effect. International Journal of Research and Scientific Innovation. July 2018,ISSN 2321–2705.
7. Neha Sharma, Meenal Rane*, Shaikh Gulam Moin. Dopaminergic Agents: Back To The Basics – A Small Review .Journal Of Applied Pharmaceutical Research. 2017 June 18. DOI: 10.18231/2348-0335.2017.0008.
8. Madhura Mestry, Meenal Rane*, Pramod Kadu, Snehal More. Self-Emulsifying Drug Delivery System Of Rosuvastatin Calcium. International Journal of Pharmacy.2017 Nov27. ISSN 2249-1848.
9. Shaikh Gulam Moin, Neha Sharma, Meenal Rane*. Novel Drug Delivery System: A Promising Approach In Management Of Schizophrenia – A Review. Journal Of Applied Pharmaceutical Research.2017 June 11. DOI: 10.18231/2348-0335.2017.0007. 
10. Meenal M. Rane* and Amrita Bajaj. Development and optimisation of novel oral formulation of an opioid analgesic using central composite design. Cogent medicine (Group of Taylor and Francis). 2017 May09. https://doi.org/10.1080/2331205X.2017.1326210.
11. Madhura Mestry, Amrita Bajaj, Meenal Rane*and Kausani Lalan. Herbal CNS stimulants. International Journal of Herbal medicines. 2016 Oct 18. 4(6): 109-116. E-ISSN: 2321-2187;P-ISSN: 2394- 0514;IJHM 2016; 4(6): 109-116

List of Publications

1. Gangane P, Sahare A, More S, Warokar A, Borkar M, Dangre P. Preparation and impregnation of deep eutectic solvents containing zileuton onto adsorbents to elicit the biopharmaceutical attributes. Journal of Molecular Structure. 2024 Sep;1312:138655.

2. Nadar S, Borkar MR, Khan T. Identification of potential focal adhesion kinase (FAK) inhibitors: a molecular modeling approach. Journal of biomolecular structure & dynamics.:1-1.

3. Singh S, Borkar MR, Bhatt LK. Transposable Elements: Emerging Therapeutic Targets in Neurodegenerative Diseases. Neurotoxicity Research. 2024 Jan 25;42(1):9.

4. Vadak N, Borkar MR, Bhatt LK. Deciphering neuroprotective mechanism of nitroxoline in cerebral ischemia: network pharmacology and molecular modeling-based investigations. Molecular diversity. 2024.

5. Khivansara R, Jadhav S, Borkar M, Sherje A. A Concise Review on Analytical Methods for Determination of Nilotinib. Current Analytical Chemistry. 2023 Aug 1;19(7):513-30.

6. Borkar MR, Khade K, Sherje A. A comprehensive review on structural attributes of biofilm inhibitors against potential targets. Journal of Molecular Structure. 2023 Dec;1293:136262.

7. Solanki A, Savla SR, Borkar MR, Bhatt LK. Sulfamethizole attenuates poloxamer 407-induced atherosclerotic neointima formation via inhibition of mTOR in C57BL/6 mice. Journal of Biochemical and Molecular Toxicology. 2023 Feb 17:e23322.

8. Dangre PV, Korekar PP, Borkar MR, Chaturvedi KK, Borikar SP, Pethe AM. Tailoring Deep Eutectic Solvents to Provoke Solubility and Bioavailability of Naringin: Implications of a Computational Approach. ACS Omega. 2023 Apr 4;8(14):12820.

9. Dangre, Pankaj V., Harshada P. Borase, Mahendra C. Gunde, Anil M. Pethe, and Maheshkumar R. Borkar. "Deep eutectic solvents: fundamental aspect, characterizations and applications." Recent Advances in Drug Delivery and Formulation, 2023, 3-12.

10. Borkar Maheshkumar R*, Coutinho E. Amalgamation of comparative protein modeling with quantitative structure-retention relationship for prediction of the chromatographic behavior of peptides, Journal of Chromatography A. 2022, Volume 1669, 462967. IF= 4.601.

11. Borase H, Borkar Maheshkumar R, Chaturvedi K, Mahapatra D, Chalikwar S, Dangre P. Design and evaluation of natural deep eutectic solvents system for chrysin to elicit its solubility, stability, and bioactivity, Journal of Molecular Liquid, Volume 345, 118205. IF= 6.663
12. Borkar Maheshkumar R *, Martis EAF, Nandan S, Patil RH, Shelar A, Iyer KR, Raikuvar K, Desle D, Coutinho EC. Identification of potential antileishmanial 1,3-disubstituted-4-hydroxy-6-methylpyridin-2(1H)-ones, in vitro metabolic stability, cytotoxicity and molecular modeling studies, Chemico-Biological Interactions, Volume 351, 109758. IF= 5.168   
13. Solanki A, Savla SR, Borkar Maheshkumar R, Bhatt LK. “Sulfamethizole attenuates poloxamer 407-induced atherosclerotic neointima formation via inhibition of mTOR in C57BL/6 mice”. IF= 3.568.
14. Dangre, Pankaj; Korekar, Pawan; Borkar, Maheshkumar; Chaturvedi, Kaushalendra; Borikar, Sachin; Pethe, Anil "Tailoring Deep Eutectic Solvents to Provoke Solubility and Bioavailability of Naringin: Implication of Computational Approach". IF= 4.132
15. Wijayasinghe YS, Bhansali MP, Borkar Maheshkumar R, Chaturbhuj GU, Muntean BS, Viola RE, Bhansali PR. A Comprehensive Biological and Synthetic Perspective on 2-Deoxy-d-Glucose (2-DG), A Sweet Molecule with Therapeutic and Diagnostic Potentials, Journal of Medicinal Chemistry (ACS), 2022, Volume 65, 5, 3706–3728. IF= 8.039.
16. P. V. Dangre , H. P. Borase , M. C. Gunde , A. M. Pethe and Borkar Maheshkumar R "Deep eutectic solvents: fundamental aspect, characterizations and applications "submitted for the journal "Recent Advances in Drug Delivery & Formulation".
17. Book Chapter: Pharmacophore Modeling, Book Title: Computational Approaches in Drug Discovery, Development and Systems Pharmacology, Publisher: Elsevier Science Direct.

List of publications

1. Ansari A; Bhatia N; Gharat Sankalp; Godad Angel & Doshi Gaurav, “Exploring Cytokines as Potential Target in Peptic Ulcer Disease: A Systematic Update. Endocrine, Metabolic & Immune Disorders - Drug Targets, January 2023, 23(1), 21-34. (IF: 2.387)
2. Ansari A; Bhatia N; Gharat Sankalp;  Godad Angel & Doshi Gaurav , Exploring Cytokines as Potential Target in Peptic Ulcer Disease: A Systematic Update Endocrine, Metabolic & Immune Disorders - Drug Targets, August  2022, 23(1), 21-31(IF:2.895)Review article(Online ahead of print) . 10.2174/1871530322666220829142124
3. Shah P; Siddique A; Thakkar A; Gharat Sankalp Godad Angel; Kale Pravin & Doshi Gaurav, An update on novel therapeutic intervention in Rheumatoid arthritis. International Immunopharmacology, August 2022, 109, 1-16(IF: 5.714) Review article.  10.1016/j.intimp.2022.108794
4. Mhapankar N; Siddique A.; Doshi Gaurav; Godad Angel & Zine Sandip, Deciphering the Role of β-Lactamase Inhibitors, Membrane Permeabilizers and Efflux Pump Inhibitors as Emerging Targets in Antibiotic Resistance. Indian Journal of Microbiology, October 2022, 62, 524-530 (IF: 2.21) Review article https://link.springer.com/article/10.1007/s12088-022-01045-6
5. Kelkar Siddesh, Nailwal Namrata, Bhatia Yogesh Nirav, Doshi Gaurav, Sathaye Sadhana & Godad Angel, An Update on Proficiency of Voltage-gated Ion Channel Blockers in the Treatment of Inflammation-associated Diseases, Current Drug Targets, November 2022; 23(14). 1290-1303. (IF: 2.937) Review article 10.2174/1389450123666220819141827
6. Doshi Gaurav; Sathaye S; Bhatia N & Godad Angel, Unraveling the immunomodulatory potential of cyprinus carpio. Journal of Young Pharmacists April 2022, 14(2), 1-4 Review Article. doi:10.5530/jyp.2022.14.30.
7. Nailwal N; Bhatia N; Ali A;Ansari A; Raheja Radhika ; Godad Angel & Doshi Gaurav, in the book titled , Marine Antioxidants Preparations, Syntheses, and Applications, chapter named Antioxidants obtained from marine sources 45, 2022, Elsevier, ISBN: 978-0-323-95086-2. https://doi.org/10.1016/B978-0-323-95086-2.00011-4 (Book Chapter).
8. Evaluation of polyherbal extracts for in-vitro antiurolithiatic activityusing bioenhancer. European Journal Biomedical and Pharmaceutical Sciences,Vol. 1, Issue 3, pp. 480-489, December 2014.
9. Screening of diabetes risk for undiagnosed diabetics in coastal regionof maharashtra: An investigational report, Vol. 4 , Issue 3, pp. 144-146,January 2014.
10. Advances in diabetes mellitus: a contemporary review, American Journalof Pharmacy and Health Research, Vol. 1, Issue 5, pp. 25-40, August 2013.
11. Gastroprotective activity of the aqueous extract from the roots ofDaucus Carota l in rats. International Journal of Research in Ayurveda andPharmacy, Vol. 1, Issue 1, pp. 112-119, Sep-Oct 2010.
12. Evaluation of in vitro anthelmintic activity of Ceratophyllum demersumlinn”, Indian Drugs 47(8), pp. 63-65, August 2010.

List of Publications

1. Singh Prabha;  Waghambare P; Khan Tabassum  & Omri A, Colorectal cancer management: strategies in drug delivery, Expert Opinion on Drug Delivery,  July 2022, 19(6), 653-670 (IF: 6.648) DOI:10.1080/17425247.2022.2084531
2. Dudhat S; Singh Prabha & Pimpale Prachi, Insights of Lipid Vesicular and Particulate Carrier Mediated Approach for Acne Management, Current Drug Delivery. November 2022, 20(1), 57 – 74(3.758) DOI: 10.2174/1567201819666220524154448
3. Ghosalkar S; Singh Prabha & Ravikumar Padmini, Emerging topical drug delivery approaches for the treatment of atopic dermatitis, Journal of Cosmetic Dermatology, February 2022, 21(2), 536 – 549 (IF: 2.696) DOI: 10.1111/jocd.14685
4. Pimpale Prachi; Singh Prabha; Prabhu Arati & Gupta S, Development and optimization of HP-β-CD inclusion complex-based fast orally disintegrating tablet of pitavastatin calcium, Journal of Pharmaceutical Innovation, September 2022, 17, 993 – 1010 (2.538) DOI: https://link.springer.com/article/10.1007/s12247-022-09661-x.  
5. Shweta Singh, Prabha Singh, Effect of Modifications in Poly (Lactide-co-Glycolide) (PLGA) on Drug Release and Degradation Characteristics: A Mini Review. Curr Drug Deliv. 2021. DOI: 10.2174/1567201818666210510165938. Online ahead of print.
6. Pritam Kamble and Prabha Singh, “A Critical Review on Potential Advancements of Nanostructured Lipid Carriers in Drug Delivery”, Current Nanomedicine (2020) 10: 1: 1-28. DOI:https://doi.org/10.2174/2468187310999200818110030
7. Singh P and Dabre S; “Controlled Release Gel Encompassing Curcumin Microspheres and Diclofenac Diethylamine for Feat Against Arthritis Inflammation”, Current Rheumatology Reviews (2020) 16(2): 110-119. DOI: 10.2174/1573397115666191105142827.
8. Singh P and Dabre S; Novel spectrophotometric method for simultaneous determination of curcumin and diclofenac diethylamine in developed dosage form: Int J Pharm Sci & Res 2020; 11(3): 1473-78. doi: 10.13040/IJPSR.0975-8232.11(3).1473-78. Impact Factor: 0.83
9. Raksha Acharya, Prabha Singh; Nanoparticles: Therapeutic Benefits for Diabetes Mellitus by Oral Delivery, International Journal of Pharm Science Review and Research, 2019; 55(2) Article no 16: 91 – 99
10. Huda Ansari, Prabha Singh; Formulation and in-vivo Evaluation of Novel Topical Gel of Lopinavir for Targeting HIV; Current HIV Research, 2018, 16, 1-10 DOI:10.2174/1570162X16666180924101650. Impact Factor: 1.562
11. Huda Ansari, Prabha Singh; Lipid Based Anti-Retroviral Nanocarriers: A Review of Current Literature and Ongoing Studies, Drug Delivery Letters, 2017; Vol. 7, No. 2, 71 – 82, Bentham Publication
12. Nivedita Bhatkal, Shreya Dhopavkar, Pramod Kadu Prabha Singh; Design, Development And Evaluation 0f Chronotherapeutic Tablets Containing Boswellia Serrata and Ginger Officianales in the Treatment of Arthritis. Indo American Journal of Pharmaceutical Sciences. 2017, Vol 4 Issue 1: 46 – 59.
13. Prabha Singh, Huda Ansari, Shalan Dabre. Niosomes- a novel tool for anti-ageing cosmeceuticals, Indo American Journal of Pharmaceutical Research 2016; Volume 6 Issue 10: 6691-6703
14. Prabha A. Singh, Amrita Narayan Bajaj, Anjali Harikrishna Singh. Formulation and In Vitro - In Vivo Evaluation of Bilayer Floating-Bioadhesive Famotidine Tablets. Int J Pharm 2013; 3(3): 548-555
15. Prabha Singh, Amrita Bajaj, Pranjali Apsegaonkar. Design Development and Evaluation of Matrix Tablets of Ambroxol Hydrochloride: In Vitro – In Vivo Study. Int J Pharm Pharm Sci. 2014; Vol 6, Issue 6: 445-449

1. Pimple Prachi; Singh Prabha; Prabhu Arati & Gupta S, Development and optimization of HP-β-CD inclusion complex-based fast orally disintegrating tablet of pitavastatin calcium.  Journal of Pharmaceutical Innovation, September 2022, 17, 993 – 1010 (IF: 2.538) Research article.   https://link.springer.com/article/10.1007/s12247-022-09661-x
2. Dudhat S; Singh Prabha & Pimpale Prachi, Insights of lipid vesicular and particulate carrier mediated approach for acne management, Current Drug Delivery, November 2022, 20(1), 57 – 74 ( IF : 3.758) Review article. 10.2174/1567201819666220524154448.
3. Solubilization of water Insoluble Class II drugs, International Multidisiplinary Research Journal Volume (6) Issue - 11 , May – 2017, Page 1-5.
4. Importance of Solubility Studies in Pharmacy, International Multidisiplinary Research Journal Volume (7) Issue - 4 , May – 2017, Page 1-5.
5. Simultaneous Determination of Dexibuprofen and Tramadol HCl by HPTLC Method, International Journal of Pharmaceutical Chemistry and Analysis, 4(3) October 2017:79-82
6. Determination of Dexibuprofen and Tramadol HCl  by simultaneous uv spectroscopic method from bulk and pharmaceutical dosage form, International Journal of Research in Pharmacy and Chemistry, 10(2) April 2020, 254-259. 
7. Ozone therapy: a paradox or panacea in various ailments. International Journal of Pharmaceutical Sciences and Research (IJPSR), February 2021; 12(2): 754-59. ( Impact Factor1.23)  

1. Pise N; Prabhu Arati,  Raheja Radhika and Dhala I, Therapeutic Peptides: Unravelling Conformational Dynamics by Systematic Application of Biophysical Techniques, Current Protein & Peptide Science, October 2022, 23(9), 619-641(IF: 3.272) DOI: 10.2174/1389203723666220908150054
2. Fuloria N; Raheja Radhika; Shah K; Oza Manisha; Kulkarni Y; Subramaniyan V; Sekar M and Fuloria S, Biological activities of meroterpenoids isolated from different sources, Frontiers in Pharmacology, September 2022, 1-36 (IF: 5.988), DOI: 10.3389/fphar.2022.830103
3. Chamriya R; Raheja Radhika; Suvarna Vasanti & Bhandare R, A critical review on phytopharmacology, spectral and computational analysis of phytoconstituents from Streblus asper Lour, Phytomedicine Plus, February 2022, 2(1), 100177. (Scopus indexed) DOI:https://doi.org/10.1016/j.phyplu.2021.100177
4. Govindarao K; Srinivasan N; Suresh R; Raheja Radhika Annadurai S;  Bhandare R  Shaik A, Quinoline conjugated 2-azetidinone derivatives as prospective anti-breast cancer agents: In vitro antiproliferative and anti-EGFR activities, molecular docking and in-silico drug likeliness studies, Journal of Saudi Chemical Society, May 2022, 26(3), 101471 (IF: 3.932) DOI: https://doi.org/10.1016/j.jscs.2022.101471
5. Nailwal N; Bhatia N; Ali A;Ansari A; Raheja Radhika ; Godad Angel & Doshi Gaurav, in the book published, Marine Antioxidants, Marine Antioxidants Preparations, Syntheses, and Applications, ISBN 978-0-323-95086-2, Elsevier. https://www.sciencedirect.com/science/article/pii/B9780323950862000114?via%3Dihub (Book Chapter)

1. Gharat, Sankalp, Vivek Basudkar, Munira Momin, and Arati Prabhu. "Mucoadhesive Oro-Gel–Containing Chitosan Lipidic Nanoparticles for the Management of Oral Squamous Cell Carcinoma." Journal of Pharmaceutical Innovation (2023): 1-18. (Impact Factor- 2.538) 
2. Ansari, Alveera Z., Nirav Yogesh Bhatia, Sankalp Ashok Gharat, Angel Pavalu Godad, and Gaurav Mahesh Doshi. "Exploring Cytokines as Potential Target in Peptic Ulcer Disease: A Systematic Update." Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders) 23, no. 1 (2023): 21-34. (Impact Factor- 2.387) 
3. Sakpal, Darshana, Sankalp Gharat, and Munira Momin. "Recent advancements in polymeric nanofibers for ophthalmic drug delivery and ophthalmic tissue engineering." Biomaterials Advances (2022): 213124. (Impact Factor- 8.457)
4. Shah, Pritha, Aqsa Siddique, Ami Thakkar, Sankalp Gharat, Angel Godad, Pravin Kale, and Gaurav Doshi. "An update on novel therapeutic intervention in Rheumatoid arthritis." International Immunopharmacology 109 (2022): 108794. (Impact Factor-5.714) 
5. Patel, Zeeshan, Sankalp A. Gharat, Moawia M. Al-Tabakha, Akram Ashames, Sai HS Boddu, and Munira M. Momin. "Recent advancements in electrospun nanofibers for wound healing: polymers, clinical and regulatory perspective." Critical Reviews™ in Therapeutic Drug Carrier Systems 39, no. 4 (2022). (Impact Factor- 4.889) 
6. Basudkar, Vivek, Sankalp A. Gharat, Munira M. Momin, and Mihika Shringarpure. "A Review of Anti-Aging Nanoformulations: Recent Developments in Excipients for Nanocosmeceuticals and Regulatory Guidelines." Critical Reviews™ in Therapeutic Drug Carrier Systems 39, no. 3 (2022). (Impact Factor- 4.889) 
7. Gupta, Bharti, Varsha Mishra, Sankalp Gharat, Munira Momin, and Abdelwahab Omri. "Cellulosic polymers for enhancing drug bioavailability in ocular drug delivery systems." Pharmaceuticals 14, no. 11 (2021): 1201. (Impact Factor- 4.286) 
8. Momin, Munira, Varsha Mishra, Sankalp Gharat, and Abdelwahab Omri. "Recent advancements in cellulose-based biomaterials for management of infected wounds." Expert Opinion on Drug Delivery 18, no. 11 (2021): 1741-1760. (Impact Factor- 6.68) 
9. Desai, Neha, Munira Momin, Tabassum Khan, Sankalp Gharat, Raghumani Singh Ningthoujam, and Abdelwahab Omri. "Metallic nanoparticles as drug delivery system for the treatment of cancer." Expert opinion on drug delivery 18, no. 9 (2021): 1261-1290. (Impact Factor- 5.4) 
10. Shringarpure, Mihika, Sankalp Gharat, Munira Momin, and Abdelwahab Omri. "Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery." Expert Opinion on Drug Delivery 18, no. 2 (2021): 169-185. (Impact Factor- 5.4) 
11. Khan, T., S. Gharat, M. Chalke, and M. Momin. "DEVELOPMENT OF SIMULTANEOUS SPECTROPHOTOMETRIC METHOD FOR QUANTIFICATION OF RESVERATROL AND FOLIC ACID IN AN OROGEL." carcinogenesis 3, no. 4: 5-6. (Impact Factor- 0.94) 
12. Bhavsar, Chintan, Munira Momin, Sankalp Gharat, and Abdelwahab Omri. "Functionalized and graft copolymers of chitosan and its pharmaceutical applications." Expert Opinion on Drug Delivery 14, no. 10 (2017): 1189-1204. (Impact Factor- 5.4) 
13. Gharat, Sankalp A., Munira M. Momin, and Chintan Bhavsar. "Oral squamous cell carcinoma: current treatment strategies and nanotechnology-based approaches for prevention and therapy." Critical Reviews™ in Therapeutic Drug Carrier Systems 33, no. 4 (2016). (Impact Factor- 4.889) 

1. Panchal Urvashi, Gharat Sankalp, Momin Munira. Exploring the potential of Stem Cell Therapy for management of Rheumatoid Arthritis- Opportunities, Challenges and Future Prospective. Association of Pharmaceutical Teachers of India (APTI) Women’s Forum Newsletter, Aug-Dec 2022 Edition, pg. no-44 (Jan 2023) APTI-WF-NL_2022_Q3_new.pdf (aptiindia.org) 
2. Use of quality excipients leads to innovations in drug delivery. Ingredients South Asia. Saffron Media Publication. Pg.no-20, Volume 14, Issue 14 16th April 2021 

List of Publications

1. Mhapankar N; Siddique A.; Doshi Gaurav; Godad Angel & Zine Sandip, Deciphering the Role of β-Lactamase Inhibitors, Membrane Permeabilizers and Efflux Pump Inhibitors as Emerging Targets in Antibiotic Resistance. Indian Journal of Microbiology 2022, 62, 524-530 (IF: 2.21) DOI: https://link.springer.com/article/10.1007/s12088-022-01045-6
2. AntivirulenceTherapy- A Promising Alternative Technique for Antibiotic Resistance, Research& Reviews: A Journal of Bioinformatics, ISSN: 2393-8722, 7(3), 01-14.
3. Nitrosamine: The Carcinogenic Impurity in AngiotensinReceptor Blockers, Research & Reviews: Journal of Oncology andHematology, ISSN: 2319-3387, Volume 9, Issue 3, Page No. 36-43.
4. Design, developmentand optimization of Valsartan and Amlodipine Micro tablets, Internationaljournal of pharmaceutical science review and research, 65(2), NovemberDecember 2020, Page no. 32-39.
5. Estimation ofamlodipine and valsartan from micro tablets, International journal ofpharmaceutical science and research, 4(2), April 2019, Page no. 1-6.
6. Comparative studyof five different marketed tablet containing amlodipine & valsartan, Internationaljournal of pharmaceutical science and research, 4(1), January 2019,Page no. 66-70.
7. The rise of superbugs, Journal of chemical and pharmaceutical research, 10(3),2018, Page no. 97-103.
8. Rise of antibioticresistance in tuberculosis, Research Journal of Pharmacy and Technology,11(7), Jul 2018, Page no. 3201-3204.
9. Microwave assistedsynthesis of biphenyl-based Schiff’s bases and their antimicrobial evaluation, Indiandrugs, 55(3), March 2018, Page no. 13-18.
10. N-methyl-D-aspartate(NMDA) receptors: potential target for neurodegenerative diseases, Biopharmjournal, 1(1), 2017, Page no. 1-13.
11. Elucidation offlavonoids from Carissa congesta, Polyalthia longifolia, and Benincasahispida plant extracts by hyphenated technique of liquidchromatography-mass spectroscopy, Pharmacognosy research, 8(4),Oct-Dec 2016, Page no. 281-286.
12. Medicinal chemistryof nanoparticles for cancer theranostics, Research & Reviews: A Journal of Drug Design & Discovery, 3(3), 2016, Page no. 28-41
13. Structural elucidation of chemical constituents from Benincasa hispida seeds and Carissacongesta roots by gas chromatography: mass spectroscopy, Pharmacognosy research, 7(3), Jul-Sep 2015, Page no. 282-293
14. Solicitation ofHPLC and HPTLC techniques for determination of rutin from Polyalthialongifolia thwaites, Pharmacognosy research, 6(3), Jul-Sep2014, Page no. 234-239.
15. Cold extraction of Carissacongesta wight monitored by a comparative revision of HPLC and HPTLC, Pharmacognosy communications, 4(2), Apr-Jun 2014, Page no. 29-33.
16. Development ofsingle unit floating-pulsatile site-specific drug delivery system forchronotherapeutic release of aceclofenac, International journal ofapplied biology and pharmaceutical technology, 2(2), April-June 2011,Page no. 339-348.
17. Quantitative estimation of piperine in Piper nigrum and Piper longum usinghigh performance thin layer chromatography, Journal of applied pharmaceutical science, 1(3), 2011, Page no. 117-120.
18. Characterization of 5-HT_1A receptor by QSAR studies on the 5-HT_1A receptor antagonists, Indian drugs, 45(5), May 2008, Page no. 354-361

1. Mehta, Namrashee V., Arundhati Abhyankar, and Mariam S. Degani. "Elemental exchange: Bioisosteric replacement of phosphorus by boron in drug design." European Journal of Medicinal Chemistry (2023): 115761.

2. Shinde R; Suvarna Vasanti & Abhyankar Arundhati, An insight into privileged scaffolds in tuberculosis: developmental aspects and implications in drug design, Indian Drugs, January 2022, 59(1), 7-22. (Scopus Indexed) Research article. 10.53879/id.59.01.13140

3. Patel S; Sandha K; Waigankar A; Jain P & Abhyankar Arundhati, “Atropisomerism transforming anti-cancer drug discovery”, Chemical Biology & Drug Design, January 2023, 101(1), 138-157(IF: 2.873)
4. Arundhati Chandrashekhar Lele, Deepak Amarnath Mishra, MariamSohel Degani et.al. Repositioning of DHFR Inhibitors. Current Topics inMedicinal Chemistry. 2016; 16(19):2125–2143. 
5. ArundhatiC. Lele, Mihir P. Khambete, Mariam S. Degani et.al., Design andsynthesis of novel Mycobacterium tuberculosis DHFR inhibitors. InternationalJournal of Pharmaceutical Sciences and Research; 2016; 7(6):2352–2356. 
6. ArundhatiC. Lele, Archana Raju, Mariam S. Degani et.al., Design andSynthesis of a Focused Library of Diamino Triazines as Potential Mycobacteriumtuberculosis DHFR Inhibitors. ACS Med. Chem. Lett. 2015; 6(11):1140–1144. 
7. ArundhatiC Lele, Archana Raju, Mariam S Degani et.al., Design and synthesisof diaminotriazines as anti-tuberculosis DHFR inhibitors. Current Research inDrug Discovery. 2014;1(2):45–50. 
8. Tawari, Nilesh R.; Lele, Arundhati C.; Degani, Mariam Set.al., Rational drug design, synthesis and biological evaluation ofdihydrofolate reductase inhibitors as antituberculosis agents. Future MedicinalChemistry .2015; 7(8):979–988 

Publications:

1. Nikhil Jadhav, Akshata Pahelkar, Neha Desai, and Vikas Telvekar, Design, Synthesis and molecular docking study of novel pyrrole based α-amylase and α-glucosidase inhibitors, Medicinal Chemistry Research, 2017, 26, 2675-2691.
2.  Akshata Pahelkar and Hemchandra Chaudhari, Preparative-scale synthesis of amino coumarins through new sequential nitration and reduction protocol, Tetrahedron letter, 2017, 58(43), 4107-4110.
3. Akshata Pahelkar and Hemchandra Chaudhari, 3D QSAR and Docking, Molecular dynamics simulations studies of Extended Side Chain of the Antitubercular Drug (6S) -2-Nitro-6-{[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3] oxazine.. Chaudhari, Infectious Disorder-Drug Target, 2019, 19(2), 145-166.
4. Jaishree Mali, Yogesh Sutar, Akshata Pahelkar, Preeti  verma  and Vikas Telvekar, Novel fatty acid-thiadiazole derivatives as potential Antimycobacterial agents, Chemical Biology and Drug Design,2020,95(1),174-181.
5. Akshata Pahelkar, Pritam Bagwe, Khushboo Maurya, Nikhil Pahelkar, Shreerang  Joshi, Vikas Telvekar, In-silico studies for design and development of inhibitor against Covid-19 in Journal of Innovations, Pharmaceutical and Biological Sciences (JIPBS),2021,8(1),14-24.

List of Publications

1. Ganwir Prerana; Bandivadekar P & Chaturbhuj G, Sulfated polyborate as bronsted acid catalyst for knoevenagel condensation, Results in Chemistry, November 2022, 4, 100632(Scopus indexed) Research article, DOI: https://doi.org/10.1016/j.rechem.2022.100632
2. P. Ganwir and G. Chaturbhuj, “Sulfated polyborate: A dual catalyst for the reductive amination of aldehydes and ketones by NaBH4,” Tetrahedron Lett., vol. 74, p. 153143, Jun. 2021, doi: 10.1016/j.tetlet.2021.153143.
3. P. Ganwir, I. Kale, and G. Chaturbhuj, “Wet copper-slag: A new and eco-friendly catalyst for Knoevenagel condensation,” Sustain. Chem. Pharm., vol. 25, p. 100614, Apr. 2022, doi: 10.1016/j.scp.2022.100614.
4. P. Ganwir, P. Bandivadekar, P. Kudale, and G. U. Chaturbhuj, “Catalyst-free, one-pot expeditious synthesis of polyhydroquinolines and 2-amino-4H-chromenes,” Res. Chem. Intermed., Jun. 2022, doi: 10.1007/s11164-022-04763-0.
5. A. S. Mali, P. Ganwir, and G. U. Chaturbhuj, “Aluminized Polyborate: A New and Eco-friendly Catalyst for One-pot Multicomponent Synthesis of 1,3-Diaryl-3-(arylamino)propan-1-ones via Mannich Reaction,” Org. Prep. Proced. Int., vol. 0, no. 0, pp. 1–8, May 2022, doi: 10.1080/00304948.2022.2057141.
6. B. Misal, A. Palav, P. Ganwir, and G. Chaturbhuj, “Activator free, expeditious and eco-friendly chlorination of activated arenes by N-chloro-N-(phenylsulfonyl)benzene sulfonamide (NCBSI),” Tetrahedron Lett., vol. 63, p. 152689, Jan. 2021, doi: 10.1016/j.tetlet.2020.152689.
7. B. Misal, A. Palav, P. Ganwir, and G. Chaturbhuj, “Activator free, expeditious and eco-friendly chlorination of activated arenes by N-chloro-N-(phenylsulfonyl)benzene sulfonamide (NCBSI),” Tetrahedron Lett., vol. 63, p. 152689, Jan. 2021, doi: 10.1016/j.tetlet.2020.152689.
8. B. Misal, A. Palav, P. Ganwir, and G. Chaturbhuj, “Sulfated polyborate-H2O assisted tunable activation of N-iodosuccinimide for expeditious mono and diiodination of arenes,” Tetrahedron Lett., vol. 74, p. 153154, Jun. 2021, doi: 10.1016/j.tetlet.2021.153154.

1. Khan, Afreen A., Tabassum A. Khan, and Abdelwahab Omri. "Computational Designing in Nanomedicine." In Personalized and Precision Nanomedicine for Cancer Treatment, pp. 247-275. Singapore: Springer Nature Singapore, 2024
2. Gomatam, Anish, Afreen Khan, Kavita Raikuvar, Merwyn D’costa, and Evans Coutinho. "Role of Computational Modelling in Drug Discovery for HIV." In Current Trends in Computational Modeling for Drug Discovery, pp. 157-194. Cham: Springer International Publishing, 2023.
3. Afreen A. Khan, Sannidhi S. Poojary, Ketki K. Bhave, Santosh R. Nandan, Krishna R. Iyer, and Evans C. Coutinho. "Prediction of QcrB Inhibition as a Measure of Antitubercular Activity with Machine Learning Protocols." ACS Omega (2022), https://doi.org/10.1021/acsomega.2c01613.
4. Afreen A. Khan, Elvis A. F. Martis, “When Artificial Intelligence Meets Drug Repurposing: Fight Against COVID-19”. Association of Pharmaceutical Teachers of India”, Women’s Forum, Newsletter, Oct-Dec 2021: 14-18 (non-peer reviewed).
5. Satish, Sohal, Rohan Chitral, Amitkumar Kori, Basantkumar Sharma, Jayashree Puttur, Afreen A. Khan, et al. "Design, synthesis and SAR of antitubercular benzylpiperazine ureas." Molecular Diversity 26, no. 1 (2022): 73-96, https://doi.org/10.1007/s11030-020-10158-3.

List of Publications

1. Jitta, Srinivas Reddy, Salwa, Navya Ajitkumar Bhaskaran, Shirleen Miriam Marques, and Lalit Kumar. "Recent advances in nanoformulation development of Ritonavir, a key protease inhibitor used in the treatment of HIV-AIDS." Expert Opinion on Drug Delivery 19, no. 9 (2022): 1133-1148. (Impact factor 8.129).
2. Jitta, Srinivas Reddy, Navya Ajitkumar Bhaskaran, Lalit Kumar, and Rupesh K. Shirodkar. "Development and Validation of RP-HPLC Method for Quantification of Total, Free and Entrapped Ritonavir in Lipid Nanocarriers and Drug content of Film Coated Fixed Dose Formulation." Indian Journal of Pharmaceutical Education and Research 56, no. 3s (2022): s547-s558.
3. Bhaskaran, Navya Ajitkumar, Srinivas Reddy Jitta, SriPragnya Cheruku, Nitesh Kumar, and Lalit Kumar. "Orally delivered solid lipid nanoparticles of irinotecan coupled with chitosan surface modification to treat colon cancer: preparation, in-vitro and in-vivo evaluations." International Journal of Biological Macromolecules 211 (2022): 301-315.(Impact factor 8.025)
4. Bhaskaran, Navya Ajitkumar, Amanda Velinna Fernandes, Gabriela Volfová, Chinna Raja Pydi, Lalit Kumar, Ruchi Verma, Shirleen Miriam Marques, and Rupesh Kalidas Shirodkar. "Development of cream to enhance the antifungal activity and reduce the side effects of fluconazole for the treatment of Candida albicans." Tenside Surfactants Detergents 59, no. 3 (2022): 231-239. (Impact factor 3.299)
5. Jitta, Srinivas Reddy, Navya Ajitkumar Bhaskaran, and Lalit Kumar. "Anti-oxidant containing nanostructured lipid carriers of ritonavir: Development, optimization, and in vitro and in vivo evaluations." AAPS PharmSciTech 23, no. 4 (2022): 88. (Impact factor 4.026)
6. Bhaskaran, Navya Ajitkumar, and Lalit Kumar. "Treating colon cancers with a non-conventional yet strategic approach: An overview of various nanoparticulate systems." Journal of Controlled Release 336 (2021): 16-39. (Impact factor 11.47)
7. Gourishetti, Karthik, Raghuvir Keni, Pawan Ganesh Nayak, Srinivas Reddy Jitta, Navya Ajitkumar Bhaskaran, Lalit Kumar, Nitesh Kumar, Nandakumar Krishnadas, and Rekha Raghuveer Shenoy. "Sesamol-loaded PLGA nanosuspension for accelerating wound healing in diabetic foot ulcer in rats." International Journal of Nanomedicine (2020): 9265-9282. (Impact Factor 7.033)
8. Ajitkumar Bhaskaran, Navya., Lalit Kumar, M. Sreenivasa Reddy, and Girish Pai K. "An analytical “quality by design” approach in RP-HPLC method development and validation for reliable and rapid estimation of irinotecan in an injectable formulation." Acta Pharmaceutica 71, no. 1 (2021): 57-79. (Impact Factor 3.299)
9. Gangurde, Puja K., Navya Ajitkumar Bhaskaran, Ruchi Verma, Jobin Jose, and Lalit Kumar. "Analytical method development using central composite design for estimation of lamotrigine in lipid nanoformulation." Tablet 8, no. 4 (2020).(Impact Factor 1.517)
10. Manoharan, Kishore, Navya Ajitkumar Bhaskaran, and Lalit Kumar. "Pellets and techniques of pelletization." Research Journal of Pharmacy and Technology 12, no. 12 (2019): 6157-6164.
11. Gangurde, Puja K., Navya Ajitkumar B, and Lalit Kumar. "Lamotrigine lipid nanoparticles for effective treatment of epilepsy: A focus on brain targeting via nasal route." Journal of Pharmaceutical Innovation 14 (2019): 91-111.(Impact Factor 2.538)
12. Bhaskaran, Navya, and Krishna T. Vamshi. "A review on the application of nanotechnology in the treatment of hypertension." Journal of Global Pharma Technology 7, no. 9 (2016): 25-31.
13. Bhaskaran, Navya, Manish Kumar, and Manthan Dilipkumar Janodia. "Use of social media for seeking health related information–an exploratory study." Journal of Young Pharmacists 9, no. 2 (2017): 267.

Book chapter publications:

1. Bhaskaran, Navya Ajitkumar, Naga Thirumalesh Chevala, and Lalit Kumar. "Nanopharmacokinetics, pharmacodynamics (PK/PD), and clinical relationship." In Nanomedicines for Breast Cancer Theranostics, pp. 245-268. Elsevier, 2020.
2. Bhaskaran, Navya Ajitkumar, and Lalit Kumar. "Solid lipid nanoparticles-based drug delivery for targeting brain tumors." In Nanocarriers for Drug-Targeting Brain Tumors, pp. 237-268. Elsevier, 2022.

List of Publications

1. Review Article on ““An Overview Of VaginalInfections, It’s Diagnosis And Treatment” in World Journal Of Pharmacy AndPharmaceutical Sciences, ISSN 2278 – 4357, Vol 12, Issue 5, 2023,399-414.
2. Review Article on “An Overview Of Wearable AndImplantable Medical Devices For Diseases” in World Journal Of Pharmacy AndPharmaceutical Sciences, ISSN 2278 – 4357, Vol 10, Issue 10, 2021, 488-507.
3. Review Article on “Novel Approaches for Treatmentof Diabetes” in  International Journal of Pharmaceutical research andApplications ISSN: 2249-7781,Volume 5, Issue 1, pp: 01-05.
4. Review Article on”Artificial Intelligence: TheFuture Of Pharma Industry”, Science, Technology and Development, ISSN : 0950-0707, Volume X IssueVII July 2021, 575-583.
5. An article on “Evaluation of antibacterial activity ofcrude extracts from the leaves of Annona muricata” was published inInternational journal of pharmaceutical research and development, July-2010edition

List of Publications-

1. Bagwe S, Tharappel LJ, Kaur G, Buttar HS. Bovine colostrum: An emerging nutraceutical. Journal of Complementary and Integrative Medicine. 2015 Sep 1;12(3):175-85.
2. Bagwe SM, Kale PP, Bhatt LK, Prabhavalkar KS. Herbal approach in the treatment of pancytopenia. Journal of Complementary and Integrative Medicine. 2017 Feb 14;14(1):20160053.
3. Bagwe-Parab S, Yadav P, Kaur G, Tuli HS, Buttar HS. Therapeutic applications of human and bovine colostrum in the treatment of gastrointestinal diseases and distinctive cancer types: The current evidence. Frontiers in Pharmacology. 2020 Sep 11;11:01100.
4. Kumawat VS, Bagwe-Parab S, Chintamaneni M, Kaur G. Therapeutic Interventions of Endocannabinoid Signaling in Obesity-Related Cardiovascular Dysfunction. Biochemistry of Cardiovascular Dysfunction in Obesity. 2020:267-81.
5. Ahmed Z, Pal A, Bagwe-Parab S, Kaur G, Buttar HS, Tuli HS. Role of flavonoids in obesity induced cardiovascular dysfunction. Biochemistry of Cardiovascular Dysfunction in Obesity. 2020:307-27.
6. Bagwe-Parab S, Kaur G. Molecular targets and therapeutic interventions for iron induced neurodegeneration. Brain research bulletin. 2020 Mar 1;156:1-9.
7. Chaudhari V, Buttar HS, Bagwe-Parab S, Tuli HS, Vora A, Kaur G. Therapeutic and industrial applications of curdlan with overview on its recent patents. Frontiers in Nutrition. 2021 Jun 28;8:646988.
8. Shenoy A, Banerjee M, Upadhya A, Bagwe-Parab S, Kaur G. The Brilliance of the Zebrafish Model: Perception on Behavior and Alzheimer’s Disease. Frontiers in Behavioral Neuroscience. 2022 Jun 13;16:861155.
9. Gupta DS, Parab SB, Kaur G. Promising effects of emoxypine and its succinate derivative in the management of various diseases-with insights on recent patent applications. Current Research in Pharmacology and Drug Discovery. 2022 Aug 1:100121.
10. Chaudhari V, Bagwe-Parab S, Buttar HS, Gupta S, Vora A, Kaur G. Challenges and opportunities of metal chelation therapy in trace metals overload-induced Alzheimer’s disease. Neurotoxicity Research. 2023 Jan 27:1-8.
11. Buttar HS, Bagwe SM, Bhullar SK, Kaur G. Health benefits of bovine colostrum in children and adults. InDairy in human health and disease across the lifespan 2017 Jan 1 (pp. 3-20). Academic Press.
12. Bagwe-Parab S, Kaur G, Buttar HS, Singh Tuli H. Absorption, metabolism, and disposition of flavonoids and their role in the prevention of distinctive cancer types. Current Aspects of Flavonoids: Their Role in Cancer Treatment. 2019:125-37.
13. Bagwe-Parab S, Yadav P, Buttar HS, Popli H, Kaur G. Therapeutic Applications of Bovine Colostrum Supplements, Omega-3 PUFAs, and Flavonoids in the Prevention of Noncommunicable Diseases. Handbook of Nutraceuticals and Natural Products: Biological, Medicinal, and Nutritional Properties and Applications. 2022 May 13;2:383-96.

1. Swapnil Raut, Upasna Singh, Deepaneeta Sarmah, Aishika Datta, Falguni Baidya, Birva Shah, Mariya Bohra, Priya Jagtap, Ankan Sarkar, Kiran Kalia, Anupom Borah, Kunjan R. Dave, Dileep R. Yavagal, Pallab Bhattacharya. Migraine and Ischemic Stroke: Deciphering the Bidirectional Pathway, ACS Chemical Neuroscience, 2020, 11(11), 1525-1538. (IF: 3.68) DOI: https://doi.org/10.1021/acschemneuro.0c00137. 
2. Deepaneeta Sarmah, Aishika Datta, Swapnil Raut, Ankan Sarkar, Birva Shah, Mariya Bohra, Upasna Singh, Priya Jagtap, Falguni Baidya, Kiran Kalia, Xin Wang, Kunjan R Dave, Dileep R Yavagal, Pallab Bhattacharya. The Role of Inflammasomes in Atherosclerosis and Stroke Pathogenesis, Current Pharmaceutical Design, 2020;26(34):4234-4245 (IF: 2.8) DOI: 10.2174/1381612826666200427084949. 
3. Falguni Baidya, Mariya Bohra, Aishika Datta, Deepaneeta Sarmah, Birva Shah, Priya Jagtap, Swapnil Raut, Ankan Sarkar, Upasna Singh, Kiran Kalia, Anupom Borah, Xin Wang, Kunjan R. Dave, Dileep R. Yavagal, Pallab Bhattacharya. Neuroimmune crosstalk and evolving pharmacotherapies in neurodegenerative diseases, Immunology, 2021, 162(2), 160-178 (IF: 5.01) DOI: https://doi.org/10.1111/imm.13264. 
4. Birva Shah, Priya Jagtap, Deepaneeta Sarmah, Aishika Datta, Swapnil Raut, Ankan Sarkar, Mariya Bohra, Upasna Singh, Falguni Baidya, Kiran Kalia, Anupom Borah, Kunjan R. Dave, Dileep R. Yavagal, Pallab Bhattacharya. Cerebro-Renal Interaction and Stroke, European Journal of Neuroscience, 2021, 53(4), 1279-1299 (IF:3.68) DOI: 10.1111/ejn.14983. 
5. Ankan Sarkar, Deepaneeta Sarmah, Aishika Datta, Harpreet Kaur, Priya Jagtap, Swapnil Raut, Birva Shah, Upasna Singh, Falguni Baidya, Mariya Bohra, Kiran Kalia, Anupom Borah, Xin Wang, Kunjan R Dave, Dileep R Yavagal, Pallab Bhattacharya. Post-stroke depression: Chaos to exposition, Brain Research Bulletin, 2021, 168, 74-88 DOI: 10.1016/j.brainresbull.2020.12.012. 
6. Maria Bohra, Ankan Sarkar, Swapnil Raut, Upasna Singh, Priya Jagtap, Birva Shah, Falguni Baidya, Aishika Datta, Harpreet Kaur, Deepaneeta Sarmah, Anupom Borah, Kunjan R. Dave, Pallab Bhattacharya. Polymeric nanomaterials in neuroscience, In: Advances in Polymeric Nanomaterials for Biomedical Application (Elsevier), 2021, Pages 291-307, DOI: https://doi.org/10.1016/B978-0-12-814657-6.00006-9. 

List of Publications:

1. Sarmah D, Verma G, Datta A, Vadak N, Chaudhary A, Kalia K, Bhattacharya P. Phyllanthus emblica L. regulates BDNF/PI3K pathway to modulate glutathione towards mitoprotection and neuroprotection in a rodent model of ischemic stroke. Cent Nerv Syst Agents Med Chem. 2022 Jun 7. doi: 10.2174/1871524922666220607093400 (IF: 1.76)
2. Aishika Datta, Deepaneeta Sarmah, Harpreet Kaur, Antra Chaudhary, Namrata Vadak, Anupom Borah, Sudhir Shah, Xin Wang, Pallab Bhattacharya. Advancement in CRISPR/Cas9 Technology to Better Understand and Treat Neurological Disorders, Cell Mol Neurobiol. 2023, 43(3), 1019-1035. doi: 10.1007/s10571-022-01242-3 (IF: 4.23)
3. Cardiolipin-Mediated Alleviation of Mitochondrial Dysfunction Is a Neuroprotective Effect of Statin in Animal Model of Ischemic Stroke. Deepaneeta Sarmah, Aishika Datta, Bijoyani Ghosh, Nikita Rana, Shubhrakanta Sahu, Vishal Gupta, Vrushali Thongire, Antra Chaudhary, Namrata Vadak, Harpreet Kaur, Swapnil Raut, Upasna Singh, Anupom Borah, and Pallab Bhattacharya. ACS Chemical Neuroscience, 2023, 14, 4, 709–724 (IF: 5.78)

List of Publications

1. Sonam Tanwar, Vaibhavi Garge, Determination of Pharmacological Drug Interaction of Glibenclamide and Hippophae rhamnoides in Streptozotocin (STZ) induced Diabetes Mellitus in Rat Model. IJPPR. Human, 2022; 25 (2), 538-562
2. Nikam D, Tanwar S, Kute A, Lokhande S and Yadav R. Synthesis and Evaluation of Novel Chemical Entities as Anti-Breast Cancer Agents, Indian Drugs, 2019; 56 (12), 28-31

List of Publications-

1. N Desai, M Momin, T Khan, S Gharat, RS Ningthoujam, A Omri, Metallic nanoparticles as drug delivery system for the treatment of cancer, Expert opinion on drug delivery 18 (9), 1261-1290
2. N Desai, M Momin, Colon targeted bioadhesive pellets of curcumin and cyclosporine for improved management of inflammatory bowel disease, Drug Delivery and Translational Research 10, 1288-1301
3. K Amra, M Momin, N Desai, F Khan, Therapeutic benefits of natural oils along with permeation enhancing activity, International Journal of Dermatology 61 (4), 484-507
4. N Desai, M Momin, U Singh, T Khan, A Sherje, Analytical method development and validation for simultaneous estimation of curcumin and cyclosporine by RP-HPLC, Int J Pharm Pharm Sci, 11 (2), Feb 2019, 26-33. [ISSN: 0975-1491]
5. DOI: https://doi.org/10.22159/ijpps.2019v11i2.28975
6. M Shaikh, N Desai, M Momin, LK Bhatt, Formulation Development and In-vitro/Ex-vivo Evaluation for a Polysaccharide-based Colon Targeted Matrix Tablet, Current Drug Delivery 18 (10), 1563-1573
7. M Damani, N Desai, BP Singh, RS Ningthoujam, M Momin, T Khan, Synthesis of Hollow Gold Nanoparticles-Impact of Variables on Process Optimization, Journal of Pharmaceutical Sciences 111 (10), 2907-2916
8. RM Desai, N Desai, M Momin, LK Bhatt, Sorafenib Loaded Resealed Erythrocytes for the treatment of Hepatocellular Carcinoma, Recent Advances in Drug Delivery and Formulation

List of Publications

1. Shaikh J; Patel Kavit & Khan Tabassum, Advances in pyrazole-based scaffold as cyclin-dependent kinase 2 inhibitors for the treatment of cancer, Mini Reviews in Medicinal Chemistry, January 2022, 22(8), 1211-1229 (IF: 3.862) Review article. 10.2174/1389557521666211027104957
2. Shradha Bodkhe, Mayuri Nikam, Atul P. Sherje, Tabassum Khan, Vasanti Suvarna, Kavit Patel; Current insights on clinical efficacy of roflumilast for treatment of COPD, asthma and ACOS; International Immunopharmacology 88 (2020) 106906. (IF-3.943)
3. Dravyakar BR, Khedekar PB, Khan T, Sherje AP, Patel KN, Suvarna V.Design and Development of Novel 2-(Morpholinyl)-N-substituted Phenylquinazolin-4-amines as Selective COX-II Inhibitor. Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2019; 18(1), 4-25.
4. Vasanti Suvarna*, Megha Sarkar, Pramila Chaubey, Tabassum Khan, Atul Sherje, Kavitkumar Patel and Bhushan Dravyakar; Bone Health and Natural Products- An Insight; Frontiers in Pharmacology 2018; Volume 9, Article 981. (IF-3.831)
5. Kavitkumar Patel*, SahilButala, Tabassum Khan, Vasanti Suvarna, Atul Sherje, Bhushan Dravyakar, Mycobacterial siderophore: A review on chemistry and biology of siderophore and its potential as a target for tuberculosis, European Journal of Medicinal Chemistry 157 (2018) 783-790. (IF-4.816)
6. K. Tabassum, P. Ekta, P. Kavitkumar; Imidazole and Pyrazole: Privileged Scaffolds for Anti-Infective Activity; Mini-Reviews in Organic Chemistry (2018) 15 (6) 2018, 459 - 475. (IF-1.095)
7. Tabassum Khan, KakshaSankhe, Vasanti Suvarna, Atul Sherje, Kavitkumar Patel, Bhushan Dravyakar; DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents, Biomedicine & Pharmacotherapy (2018) 103, 923–938. (IF-2.759)
8. Atul P. Sherje, Forum Patel, ManikantaMurahari, Vasanti Suvarna, Kavitkumar Patel, Study on Effect of L-Arginine on Solubility and Dissolution of Zaltoprofen: Preparation and Characterization of Binary and Ternary Cyclodextrin Inclusion Complexes” Chemical Physics Letters (2018) 694, 120-128. (IF-1.815)
9. Kavitkumar N. Patel, Vikas N. Telvekar*; Design,    synthesis   and antitubercular evaluation of        novel      series of N-[4-(piperazin-1-yl)phenyl]cinnamamide derivatives; European Journal of Medicinal Chemistry (2014) 75, 43-56.
10. Kavitkumar N. Patel, Nikhil C. Jadhav, Prashant B. Jagadhane, Vikas N. Telvekar*; An expedient route to the azoles through oxidative desulfurization using iodine reagent; Tetrahedron Letters (2013), 54 (1), 101–105.
11. Kavitkumar N. Patel, Nikhil C. Jadhav, Prashant B. Jagadhane and Vikas N. Telvekar*; A novel strategy for construction of azole heterocycles via oxidative desulfurization approach using iodobenzene and Oxone®; Synlett (2012), 23 (13), 1970–1972.
12. Vikas N. Telvekar*, Kavitkumar N. Patel; Pharmacophore Development and Docking Studies of the HIV-1 Integrase Inhibitors Derived from N-methylpyrimidones, Dihydroxypyrimidines, and Bicyclic Pyrimidinones; Chemical Biology and Drug Design (2011), 78 (1), 150–160.
13. Vikas N. Telvekar*, Kavit N. Patel, Harish S. Kundaikar, Hemchandra K. Chaudhari; A novel system for the synthesis of nitriles from aldehydes using aqueous ammonia and sodium dichloroiodate; Tetrahedron Letters (2008), 49 (14), 2213-2215.
14. Vikas N. Telvekar*, Harish S. Kundaikar, Kavit N. Patel, Hemchandra K. Chaudhari; 3D-QSAR and Molecular Docking Studies on Aryl Benzofuran-2-yl ketoxime derivatives as Candida albicans N-Myristoyltransferase Inhibitors, QSAR and Combinatorial Science (2008), 27 (10), 1193-1203.
15. J. K. Joshi*, V. R. Patel, K. N. Patel, D. Rana, K. A. Shah, R. D. Patel, R. Patel, Synthesis and Anti-inflammatory activity of N-arylanthranilic acid and its derivatives, Indian Journal of Pharmaceutical Science (2007), 69 (5), 697-699.

List of Publications

1. Mitali Bhauimali, ASunya Munshi, Kunali Hapa, Pramod K. Kadu, Pravin P. Kale, “Evaluation of liposomes for targeted drug delivery in lung cancer treatment”, International journal of polymeric materilas and polymeric biomaterials, (2023). (Impact Factor 3.221)
2. Tanvi Parmar, Pramod Kadu, Pravin Kale, “Critical Strategies for Drug Precipitation Inhibition : A Review with a focus on poorly soluble drugs”. Current drug delivery,20, no.5 (2023),497-507. (Impact Factor-3.758)
3. Janhavi Naik, Duttaraj Kulkarni, Pramod Kadu, Aditya Pandya, Pravin Kale, “Use of In silico tools for screening buffers to overcome physical instability of Abatacept”.Transplant Immunology,71, ,(2022),1015511.(Impact Factor-2.032)
4. Kadu Pramod, Bhakti Sawant, Pravin Kale, Kedar Prabhavalkar, “Copper chelating agents as adjuvants to chemotherapy”, Indian Journal of Pharmacology, 53, no. 3 (2021),221-225. (Impact Factor-2.833)
5. Shreya M Palwankar, Pravin P Kale, Pramod K Kadu, Kedar Prabhavalkar, “Assessment of Antidiabetic Activity of Combination of Murraya koenigii Leaves Extract and Vitis vinifera Seeds Extract in Alloxan-induced Diabetic Rats”, Journal of Reports in Pharmaceutical Sciences,9 no.1 (2020),79-85.
6. Ruchita Ravindra Dhangar, Pravin Popatrao Kale, Pramod Kerunath Kadu, Kedar Prabhavalkar, “Possible Benefits of Considering Glutamate with Melatonin or Orexin or Oxytocin as a Combination Approach in the Treatment of Anxiety”, Current Pharmacology Reports,6 no.1 (2020),1-7.
7. Jegan Sakthivel Nadar, Pravin Popatrao Kale, Pramod Kerunath Kadu, Kedar Prabhavalkar, “Ruchita Dhangar, Potentiation of antidepressant effects of agomelatine and bupropion by hesperidin in mice, Neurology research international”,7 no.1 (2018),61-67.
8. Shreya Dhopavkar, Nivedita Bhatkal, Pramod Kadu, Design and development of a topical anti-fungal transfersomal gel, Latin American Journal of Pharmacy,36,no.8 (2017),1618-1630.
9. Dheeraj L. Patingrao and Pramod Kadu, “Formulation and evaluation of clarithromycin gastroretentive dosage form”, J. Chem. Pharm. Res.”,6, no.7,(2014),82-89.
10. Amrita bajaj, Pramod kadu, Nandkumar chodankar, “Topical film forming spray formulations of s-ibuprofen”,International journal of pharmaceutical research and bio-science,4, no.3 (2015),180-196.
11. Vishal Rokade and Dr. Pramod Kadu ,Formulation and evaluation of novel anti-bacterial ciprofloxacin loaded niosomal cream,Int. Res. J. Pharm.6, no.8 (2015),,519-527.
12. Sneha Sawant, pramod Kadu, Sweta Savla, Vishal Rokade and Ankita Surjuse, Solubilization: “A Bane for Anti-malarial Drugs, International Journal of Pharmaceutical Research”,7, no.3 (2015),1-8.
13. Pramod Kadu, Preeti Sangave, “Enzymatic method for the synthesis of glyceryl monosterate, Journal of Pharmacy Research”,3, no.2(2010),386-387.
14. T Choche, S Shende, “ P Kadu Extraction and identification of bioactive components from Aloe barbadensis Miller,, - Res Rev J Pharmacogn Phytochem,3, no.2,(2014),14-23.

List of Publications

1. Mrunal Jadhav, Tabassum Khan et al., Synthetic Strategies of Pyrimidine-Based Scaffolds as Aurora Kinase and Polo-like Kinase Inhibitors, Molecules. 2021; 26(17):5170. Impact Factor (IF)- 4.9
2. Mrunal Jadhav, Tabassum Khan et al., Novel therapeutic approaches for targeting TB and HIV reservoirs prevailing in lungs, Expert Opinion on Drug Delivery, 2019, 16:7, 687-699. Impact Factor (IF)- 6.6
3. Atul Sherje and Mrunal Jadhav, β-Cyclodextrin-based inclusion complexes and nanocomposites of rivaroxaban for solubility enhancement, Journal of Materials Science: Materials in Medicine, 2018, 29:186. IF- 2.5
4. Atul Sherje, Mrunal Jadhav et al., Dendrimers: A versatile nanocarrier for drug delivery and targeting, International Journal of Pharmaceutics, 2018, 548:707-720. IF- 6.5
5. Atul Sherje, Mrunal Jadhav et al., Cyclodextrin Based Nanosponges: A Critical Review, Carbohydrate Polymers, 2017, 173:37-49. IF- 10.7

List of Publications

1. Pallar A& Kale Pravin, Combinational approaches targeting various aspects involved in intestinal barrier dysfunction-induced anxiety, Current Drug Targets. June 2022, 23(11), 1085-1098 (IF: 2.93) DOI: 10.2174/1389450123666220428093419
2. Avatade A; Kale Pravin & Todkar S, Possible targets related to connexins and ceramides in the treatment of depression using a combination approach, Journal of Reports in Pharmaceutical Sciences, June 2022, 11(1), 1-11 (Scopus Indexed) DOI:https://www.jrpsjournal.com/article.asp?issn=2322-1232;year=2022;volume=11;issue=1;spage=1;epage=11;aulast=Avatade;type=0
3. Shah P; Siddique A; Thakkar A; Gharat Sankalp Godad Angel; Kale Pravin & Doshi Gaurav, An update on novel therapeutic intervention in Rheumatoid arthritis. International Immunopharmacology, August 2022, 109, 1-16 (IF: 5.714) DOI: 10.1016/j.intimp.2022.108794
4. Doshi Gaurav; Bhatia N; Ved H; Pandya A; Kulkarni D; Naik J; Bandiwadekar T; Godad Angel & Kale Pravin, Update on Oxytocin, Phosphodiesterase, Neurokinin, Glycine as a Therapeutic Approach in the Treatment of Schizophrenia, CNS Neurological Disorder Drug Targets, August 2022 Ahead of print (IF:2.824), DOI:10.2174/1871527321666220817161035
5. Gupta V S. & Kale Pravin, Combinatory approaches targeting cognitive impairments and memory enhancement, a review, Current Drug Targets, October 2022, 24(1), 55-70 (IF: 2.937).  DOI:10.2174/1389450123666220928152743. 
6. Ved H ; Doshi Gaurav ; Bhatia N & Kale Pravin, Metoclopramide as a potential antipsychotic against long-term methionine exposure in zebrafish , Zebrafish,  December 2022,  Online ahead of print( IF : 2.229) Research article . 10.1089/zeb.2022.0033
7. Kadu Pramod; Kale Pravin; Naik J; Kulkarni D & Pandya A, Use of in silico tools for screening buffers to overcome physical instability of Abatacept, Transplant Immunology, April 2022, 71, 101551 (IF: 1.708) DOI:10.1016/j.trim.2022.101551
8. Parmar T; Kadu Pramod & Kale Pravin, Critical strategies for drug precipitation inhibition: a review with a focus on poorly soluble drugs, Current Drug Delivery April 2022, online ahead of print (IF: 2.5) DOI: 10.2174/156720181966622042712310
9. Doshi Gaurav; Kale Pravin; Bhatia N & Ved H, Importance of exploring n-methyl-d-aspartate (NMDA) as a future perspective target in depression, CNS & Neurological Disorders - Drug Targets, May 2022, 21(10), 1004 – 1016 (IF: 4.388) DOI: 10.2174/1871527321666220329141639
10. Marathe PA, Raut SB, Satam SD, Shetty YC, Pooja SG, Raut AA, Kale PP, Rege NN. Effect of Withania somnifera (L.) Dunal aqueous root extract on reinstatement using conditioned place preference and brain GABA and dopamine levels in alcohol dependent animals, Journal of Ethnopharmacology, 274, 2021, 113304, DOI: https://doi.org/10.1016/j.jep.2020.113304. (Impact factor 3.6) 
11. Jaiswal M, Kale PP. Mini review- Vanadium induced neurotoxicity and possible targets. Neurological Sciences. 2020;41:763-768. (Impact factor 2.4) 
12. Rodrigues PS, Kale PP, Bhatt LK. Neuroimaging in Parkinson’s disease. Neurological Disorders and Imaging Physics, 2020, Volume 5. Chapter 11.  [Book Chapter] 
13. Palwankar SM, Kale PP, Kadu PK, Prabhavalkar K. Assessment of Antidiabetic Activity of Combination of Murraya koenigii Leaves Extract and Vitis vinifera Seeds Extract in Alloxan-induced Diabetic Rats. Journal of Reports in Pharmaceutical Sciences. 2020. 9:79-85.
14. Dhangar R, Kale PP, Kadu PK, Prabhavalkar K. Possible benefits of considering glutamate with melatonin or orexin or oxytocin as a combination approach in the treatment of anxiety. Current Pharmacology Reports. 2020;6:1-7. 
15. John P, Kale PP. Prominence of oxidative stress in the management of Anti-tuberculosis drugs related hepatotoxicity. Drug Metabolism Letters. 2019; 13(2): 95-107. DOI: 10.2174/1872312813666190716155930 
16. Bendale M, D'souza, Addepalli V, Kale PP. Effect of bupropion augmentation with minocycline in the treatment of depression. Acta Neurobiologiae Experimentalis. 2019, 79;217-224. DOI: 10.21307/ane-2019-019 (Impact factor 1.5) 
17. Sakthivel JN, Kale PP, Kadu PK, Prabhavalkar K, Dhangar R. Potentiation of Antidepressant Effects of Agomelatine and Bupropion by Hesperidin in Mice. Neurology Research International. 2018 (2018): 9828639. https://doi.org/10.1155/2018/9828639.
18. Vallikalayil RP, Kale PP, Savai J. Evaluation of Anxiolytic effect of Zonisamide and its combination with Bupropion in mice. Indian Journal of Experimental Biology. 2018 Jan; 56(1): 54-59. (Impact factor 1.47)  
19. Bohra BS, Kale PP. Evaluation of nootropic effects of galantamine and sildenafil as a combination in mice. Indian Journal of Experimental Biology. 2018 Jan; 56(1):60-65. (Impact factor 1.47)  
20. Bagwe SM, Kale PP, Bhatt LK, Prabhavalkar KS. Herbal Approach in the treatment of pancytopenia. Journal of Complementary & Integrative Medicine. 2017; 20160053. doi: 10.1515/jcim-2016-0053.. 
21. Sawantdesai NS, Kale PP, Savai J. Evaluation of anxiolytic effects of aripiprazole and hydroxyzine as a combination in mice. Journal of Basic & Clinical Pharmacy. 2016;7:97-104. DOI 10.4103/0976-0105.189429 .
22. Kale PP, Addepalli V. Enhancement of nootropic effect of duloxetine and bupropion by caffeine in mice Indian Journal of Pharmacology. 2015;47(2):199-201. (Impact factor 0.9). DOI 10.4103/0253-7613.153430 
23. Patel S, Kale PP, Addepalli V. Sarkar A, Savai J. Effect of a combination of duloxetine with hydroxyzine on experimental models of anxiety in mice. Indian Journal of Pharmacology. 2015; 47(2):173-176. (Impact factor 0.9). DOI 10.4103/0253-7613.153424 
24. Kale PP, Addepalli V, Sarkar A, Patel S, Savai J. The combination of antidepressant duloxetine with piracetam in mice does not produce enhancement of nootropic activity. Experimental Neurobiology. 2014;23(3):224-30. (Impact factor 3.81) DOI: 10.5607/en.2014.23.3.224 
25. Kale PP, Addepalli V. Augmentation of antidepressant effects of duloxetine and bupropion by caffeine in mice. Pharmacology Biochemistry and Behavior. 2014;124:238-244. (Impact factor 2.5) DOI 10.1016/j.pbb.2014.06.005 
26. Kale PP, Addepalli V. Enhancement of anxiolytic effect of duloxetine or bupropion by caffeine in mice. Journal of Caffeine Research. 2014;4(3):69-70. (Indexed in Pubmed, Thomson Reuters, etc.) DOI  10.1089/jcr.2014.0014 
27. Kale PP, Addepalli V, Ghadawale S. Impact of pre-exposure of tail suspension on behavioural parameters like locomotion, exploration, and anxiety. Indian Journal of Experimental Biology. 2013;51(9):732-738. (Impact factor 1.47) 
28. Kale PP, Addepalli V, Bafna PA, Prabhavalker K. Caffeine-induced augmentationof antidepressant therapy. Journal of Experimental and Clinical Medicine. 2010; 2(6):282-286. (Indexed in Scopus, etc.) DOI :10.1016/j.jecm.2010.09.001 

List of Publications

1. Prabhu P; Fernandes T; Damani M; Chaubey P; Narayanan S and Sawarkar Sujata, 2 Receptor specific ligand conjugated nanocarriers: an effective strategy for targeted therapy of tuberculosis, Current Drug Delivery, January 2022, 19(8), 830-845 (IF: 2.565) Review article. 10.2174/1567201819666211216141942
2. Fernandes, T., Bhavsar, C., Sawarkar, S. and D’souza, A. Current and novel approaches for control of dental biofilm. International Journal of Pharmaceutics. 2017, 536 (1):199-210. DOI: 10.1016/j.ijpharm.2017.11.019 (IF=3.9)
3. Baxi, K., Sawarkar, S., Momin, M., Patel, V. and Fernandes, T., Vaginal siRNA delivery: overview on novel delivery approaches. Drug delivery and translational research. 2020, 10(4):962-974. DOI: 10.1007/s13346-020-00741-4 (IF= 4.67)
4. Fernandes, T., Baxi, K., Sawarkar, S., Sarmento, B. and das Neves, J., Vaginal multipurpose prevention technologies: promising approaches for enhancing women’s sexual and reproductive health. Expert opinion on drug delivery, 2020, 17(3), pp.379-393 (IF= 4.83).
5. Sawarkar, S.P., D'souza, A. and Fernandes, T., Salvadora persica L.(Miswak) An Effective Folklore Toothbrush. Natural Oral Care in Dental Therapy, 2020, pp.285-296 (Book chapter)
6. Fernandes, T., D'souza, A. and Sawarkar, S.P., Ocimum Sanctum L: Promising Agent for Oral Health Care Management. Natural Oral Care in Dental Therapy, 2020, pp.259-269 (Book Chapter).
7. Prabhu, P., Fernandes, T., Chaubey, P., Kaur, P., Narayanan, S., Ramya, V.K. and Sawarkar, S.P. Mannose-conjugated chitosan nanoparticles for delivery of rifampicin to osteoarticular tuberculosis. Drug Delivery and Translational Research, 2021, 11(4), pp.1509-1519. DOI: https://doi.org/10.1007/s13346-021-01003-7 (IF= 4.61)
8. Prabhu, P., Fernandes, T., Damani, M., Chaubey, P., Narayanan, S. and Sawarkar, S., Receptor Specific Ligand Conjugated Nanocarriers: An Effective Strategy for Targeted Therapy of Tuberculosis. Current Drug Delivery. 2022, pp. 830-845 DOI:  https://doi.org/10.2174/1567201819666211216141942 (IF = 3.75).

List of Publications

1. MP Khambete, LP Khare, AB Kapadia, MS Degani, Exploring the potential of pyrazoline containing molecules as Aβ aggregation inhibitors in Alzheimer’s disease, Drug Metabolism and Personalized Therapy 35 (3)
2. S Vyas, M Khambete, R Gudhka, S Panchamia, M Degani, V Patravale, In silico modeling of functionalized poly (methylvinyl ether/maleic acid) for controlled drug release in the ocular milieu, Drug Delivery and Translational Research 10, 1085-1094
3. S Vyas, M Khambete, R Gudhka, S Panchamia, M Degani, V Patravale, Network topology of LMWG cross-linked xyloglucan hydrogels for embedding hydrophobic nanodroplets: mechanistic insight and molecular dynamics, Drug Delivery and Translational Research 10, 1076-1084
4. S Kurve, M Khambete, R Kadam, Evaluation of in vitro melanogenesis inhibition activity of Kadamba (Anthocephalus Cadamba Miq), Indian Drugs 57 (4), 65-66
5. N Agre, M Khambete, A Maitra, A Gupta, T Munshi, S Bhakta, M Degani, Exploration of 5-(5-nitrothiophen-2-yl)-4, 5-dihydro-1H-pyrazoles as selective, multitargeted antimycobacterial agents, Chemical biology & drug design 95 (1), 192-199
6. SS De, MP Khambete, MS Degani, Oxadiazole scaffolds in anti-tuberculosis drug discovery, Bioorganic & medicinal chemistry letters 29 (16), 1999-2007
7. M Khambete, P Murumkar, A Kumar, T Darreh-Shori, S De, MR Yadav, Pyrazoline containing molecules as multifunctional agents in alzheimer’s disease, Indian Drugs 56 (10), 22-25
8. M Khambete, H Kundaikar, A Raju, S Lonkar, M Degani, MK Ray, Design and synthesis of 5-(5-nitrothiophen-2-yl)-3-phenyl-4,5-dihydro-1H-pyrazole derivatives with improved solubility and potential antituberculosis activity, Chemical Biology & Drug Design 93 (1), 84-88
9. AC Lele, MP Khambete, A Raju, M Ray, MGR Rajan, MS Degani, Design and Synthesis of Novel Mycobacterium Tuberculosis DHFR Inhibitors, International Journal of Pharmaceutical Sciences and Research 7 (6), 2352
10. AC Lele, A Raju, MP Khambete, MK Ray, MGR Rajan, MA Arkile, Design and Synthesis of a Focused Library of Diamino Triazines as Potential Mycobacterium tuberculosis DHFR Inhibitors, ACS Medicinal Chemistry Letters 6 (11), 1140-1144
11. A Raju, MS Degani, MP Khambete, MK Ray, MGR Rajan, Antifolate Activity of Plant Polyphenols against Mycobacterium tuberculosis, Phytotherapy Research 29 (10), 1646-1651
12. N Tawari, A Lele, M Khambete, M Degani, Mutagenicity prediction for nitroaromatic compounds using QSTR modeling, Int J Pharm Pharm Sci 6, 149-157
13. A Bhusari, M Degani, H Kundaikar, M Bochare, H Janmanchi, Design, synthesis and in vitro evaluation of 18F potential fluorinated molecules as PET tracers for Alzheimer's disease, Indian Journal of Nuclear Medicine 28 (5, suppl.), 47
14. NG Monica R.P Rao*, Priyanka Sadaphule, Mihir Khambete, Harshad Lunavat, Characterization of Psyllium (Plantago ovata) Polysaccharide and its Use as a Binder in Tablets, Indian Journal of Pharmaceutical Education and Research 47 (2), 154-159
15. N Gabhe, M Khambete, M Gunjal, I Patil, Therapeutic approaches in the treatment of alzheimer’s disease: a review, International Journal of Pharmacy and Biological Sciences 2 (1), 238-245
16. M Rao, N Gabhe, M Gunjal, S Bhide, H Lunavat, M Khambete, Binary And Ternary Solid Dispersions Of Fenofibrate For Solubility Enhancement, International Journal of Pharmacy and Pharmaceutical Sciences 4 (Suppl. 4 …

• Development and evaluation of peppermint oil containing microemulsions for intranasal delivery. Archives of Pharmacy Practice, 2 (3), 2011.
• Lipid characterization study in preparation of liposomes of salbutamol sulphate, Journal of Pharmacy Research, 4 (4); 2011.
• Self-nanoemulsifying drug delivery system of cefpodoxime proxetil containing tocopherol polyethylene glycol succinate. Drug Development and Industrial Pharmacy, 2012; 1–11.
• Nanocrystallization by evaporative antisolvent precipitation for enhancement of solubility and bioavailability of          emulgel, AAPS PharmSciTech.
• In vitro and in vivo evaluation of β-cyclodextrin-based nanosponges of Telmisartan. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 2012. 
• Investigation of           nanoporous colloidal carrier for solubility enhancement of Cefpodoxime proxetil’, J. of Pharmacy Research, 2012, 5(5), 2496-2499.
•  Lactic acid (PLA) nanoparticles sustain the cytotoxic action of temozolomide in C6 Glioma cells. Biomedicine & Aging Pathology (2013) 3: 201–208.
• Studies on stabilization mechanism and stealth effect of poloxamer 188 onto PLGA nanoparticles. Colloids Surf B Biointerfaces (2013)109: 59-67.
• Cyclodextrin based nanosponges and its pharmaceutical use: A Review. Acta Pharmaceutica (2013) 63(3): 335–358
• In vivo evaluation of taste masking for developed chewable and orodispersible tablets in humans and rats. Pharm Dev Technol. 2014 May; 19(3):290-5.
• Unraveling the cytotoxic potential of Temozolomide loaded into PLGA nanoparticles. DARU journal of Pharmaceutical Sciences (2014) 22(18):1-9
• Fabrication and In Vitro Evaluation of Solid Lipid Nanoparticles of Mometasone Furoate for Pulmonary Delivery. Journal of Nanopharmaceutics and Drug Delivery.
• Fabrication of lipospheres for paclitaxel and assessment of In Vitro cytotoxicity against U373 cancer cell lines. Thai Journal of Pharmaceutical Sciences. (2012) 36: 117-130 (Impact factor-0.154)
• Development of Directly Compressible Ascorbic Acid Tablet Using Novel Excipients. Journal of Advanced Scientific Research. (2012) 3(3):15-24
• In vitro assessment and comparison of intranasally administered microemulsion formulations of essential oil for Migraine. International Journal of Current Pharmaceutical Research, 3 (2), 2011.
•  Importance of visual observations in dissolution testing. Express Pharma, 2012: 41-43.
• Significance visual monitoring in in-vitro dissolution profiling. The Indian Pharmacist, 2012; 23-26.
• Taste Assessment in Humans and Rats - A Comparative Approach, Pharma Review. 2013; 134-38.
• Microporous Biodegradable Polymeric Sponge for Surgical Haemostasis and Wound Healing. Journal of Advanced Scientific Research, 2011, 2(1); 14-23.

1. Kinjal Jain, Padmini Ravikumar: Recent advances in treatments of cartilage regeneration for knee osteoarthritis,  Journal of Drug Delivery Science and Technology, 2020, Volume 60, 102014
2. Divyashree Prabhu * and Padmini Ravikumar: A strategy to surpass photo instability and low penetrability of skin lightening agents, IJPSR, 2020; Vol. 11(7): 3433-3441.
3. Diveshkumar, Amrita Date, Padmini Ravikumar and Rashmi Mallya: Pomegranate Peel: Extraction, Anthelmintic Activity and Formulation of Suspension, Jan - Jun 2020, International Journal of Pharmaceutical Research, Supplementary Issue 1,?503-509
4. Prabhu D and Ravikumar P: Microencapsulation: a strategy to surpass photo instability and low penetrability of skin lightening agents. Int J Pharm Sci & Res 2020; 11(7): 3433-41
5. Pratik P Patil, Padmini Ravikumar, Aparajita Varshneya: Formulation and Characterization of Sustained Release Multi particulate Gastroretentive Dosage Form of Baclofen, Inventi Impact: NDDS Vol 2019, (4):204-210,2019.
6. Kane-Dumbre S, Momin M, Ravikumar P, Khatri R: Drug delivery strategies for Helicobacter Pylori infection management: An overview, Indian Drugs, 2019, 56 (10),7-21
7. Divyashree Prabhu, Padmini Ravikumar: Novel user-friendly night care spray to manage skin darkening, J Cosmet Dermatol, 2019,00:1-8.
8. Padmini.R, Tatke.P, Prabhu.D: Analytical Method development and Validation For Estimation of Resveratrol and Glycyrrhetinic acid by RP-HPLC Method, J.Pharm Chem Biol Sci 2019; 7(2):138-146
9. Padmini Ravikumar and Pratima Tatke: Advances in encapsulated dermal formulations in chemoprevention of melanoma: An overview, J Cosmet Dermatol. 2019; 00: 1–7
10. Padmini Ravikumar, Mahesh Katariya, Sushil Patil, Pratima Tatke and Raviraj Pillai: Skin delivery of resveratrol encapsulated lipidic formulation   for   melanoma chemoprevention, Journal of Microencapsulation (2019):1-16.
11. Padmini Ravikumar and Pratima Tatke: Design of an encapsulated topical formulation for?Chemoprevention of skin cancer,?Int J PharmSci Res, 2019; Vol. 10(1): 309-319.
12. Dhariwala MY and Ravikumar P: An overview of herbal alternatives in androgenetic alopecia, J Cosmet Dermatol. 2019; 18: 966-975.
13. Sukanya Nagfernandes and Padmini Ravikumar: Teeth whitening effectiveness of Carbamide peroxide gel in comparison to Hydrogen peroxide gel”  Research and reviews: Journal of Dental Sciences , 2017, Volume 5, Issue 4 : 21-26.
14. Narshana M and Ravikumar P: An overview of dandruff and novel formulations as a treatment strategy. Int J Pharm Sci Res 2018; 9(2): 417-31.
15. Nasrin Shaikh and Padmini Ravikumar: An overview of current and novel treatment approaches for actinic keratosis, EJBPS, 2017, volume 4, issue 01, 116-125
16. Khushali Trivedi and Padmini Ravikumar: Topical Formulations in Psoriasis Management: An overview, Indo American Journal of Pharmaceutical Research.2016:6(11)
17. Melissa R Cardoz and Padmini Ravikumar, Design, development and evaluation of novel oral medicated jellies, Indo Am.J.P.Sci, 2017; 4(06)
18. Ankita Mistry and Padmini Ravikumar: Development and Evaluation of Azelaic acid based Ethosomes for Topical Delivery for the Treatment of Acne, Indian Journal of Pharmaceutical Education and Research, Vol 50, Issue 3 | Jul-Sep (Suppl.),
19. S. Y. Rai and Padmini Ravikumar: Development and Evaluation of Microsphere Based Topical Formulation using Design of Experiments, Indian J Pharm Sci, 2016; 78((2):182-192
20. S. Sawarkar, P. Ravikumar and S. Pashte: In-Situ Ophthalmic   Gel Forming Solution of Moxifloxacin Hydrochloride for Sustained Ocular Delivery, IJPSR, 2016, Vol. 7(3): 1192-1205
21. S Sawarkar, S. Gupta, Padmini Ravikumar: Solubility enhancement of poorly water soluble protease inhibitor International Journal of Pharmaceutical sciences and Research, 2016, Vol 7 (1)
22. Pathare Samrudhi and Ravikumar Padmini: Honey based Clotimazole Micoemulsion for topical delivery, Indo-American Journal of Pharmaceutical Research, 2016: 6(11)
23. Amol T. Rangari and Padmini Ravikumar: Polymeric Nanoparticles Based Topical Drug Delivery: An Overview Asian Journal of Biomedical and Pharmaceutical Sciences, 2015, 5(47), 05-12.
24. Rashmi Mallya and Padmini Ravikumar: Phytochemical and pharmacological studies of   stem bark of Cordia myxa Roxb extract, International Journal of Pharmaceutical Research, 2015, Vol 7, Issue 4, Oct-Dec
25. A. Mistry, Padmini Ravikumar and S Pathare: Ethosomes Unique elastic vesicular carrier : An Overview, International Journal of Pharmaceutical sciences and Research, 2015, Vol. 6, Issue 10
26. Rashmi Mallya and Padmini Ravikumar: Formulation and Evaluation of Natural Hair Colorants, International Journal of Pharmacy and Pharmaceutical Sciences, 2015, Vol 7(3),347-349
27. Samrudhi Pathare, Padmini Ravikumar and Ankita Mistry: Promising Applications of honey: A Review, World Journal of Pharmacy and Pharmaceutical Sciences, 2015, Vol 4,  Issue 5, 22
28. Varshneya Aparajita and Padmini Ravikumar: Formulation and characterisation of Rutin trihydrate Liposomes for Topical Delivery, International Journal of Pharmaceutical Research, 2015, Vol 7, Issue 3:29-37
29. Varshneya Aparajita and Padmini Ravikumar: Liposomes as carriers in skin ageing, International Journal of Current Pharmaceutical Research, 2014, Vol 6, Issue 3:1-7
30. Padmini Ravikumar and Rashmi Mallya: Development and Evaluation of a polyherbal topical formulation, JPR BioMedRx, 2013, 1(7),637-640.
31. Padmini Ravikumar, N.D. Grampurohit, Rashmi Mallya: Microemulsions for Topical Use-A Review, Ind J Pharm Edu Res, 2011, Vol 45,Issue1: 100-107

1. Date V and Nair S. Emerging vistas in CAR T-cell therapy: Challenges and opportunities in solid tumors.  Expert Opinion on Biological Therapy. 2020; Online Sep 3:1-16. doi: 10.1080/14712598.2020.1819978 (Impact Factor 3.222). 
2. Gandhi M and Nair S. New vistas in malignant mesothelioma: MicroRNA architecture and NRF2/MAPK signal transduction. Life Sciences. 2020; 257:118-123. (Impact Factor 3.647). 
3. Vasistha A, Rishi M, Mishra A, De Andres F, LLerena A, Nair S. Current insights into interethnic variability in testicular carcinogenesis: Population pharmacogenetics, chemotherapy-induced toxicities, and molecular signal transduction. Current Topics in Medicinal Chemistry. 2020; 20 (20): 1824-1838. (Impact Factor 3.402). 
4. Peñas-LLedó EM, Terán E, Sosa-Macías M, Galaviz-Hernández C, Gil JP, Nair S et al. Challenges and Opportunities for Clinical Pharmacogenetic Research Studies in Resource-Limited Settings: Conclusions From the Council for International Organizations of Medical Sciences–Ibero-American Network of Pharmacogenetics and Pharmacogenomics Meeting. Clinical Therapeutics. 2020; 42(8):1595-1610 (Impact Factor 2.947). 
5. Gulati I, Patel H, Prabhakar B, Nair S. Current translational insights into MGMT methylation regulating temozolomide sensitivity and resistance in glioblastoma multiforme. Current Pharmacogenomics and Personalized Medicine. Bentham. 2020; 17:1-18. 
6. Sodvadiya M, Patel H, Mishra A, Nair S. Emerging insights into anticancer chemopreventive activities of nutraceutical Moringa oleifera: molecular mechanisms, signal transduction and in vivo efficacy. Current Pharmacology Reports. Springer Switzerland. 2020; 6(2): 1-16. 
7. Mali A, Sawant A, Mahadik A, Nair S. Immunotherapy for Autoimmune Diseases. Book Chapter in Immunotherapy: A Novel Facet of Therapeutics, Springer Singapore (2020). Accepted. 
8. Jain R and Nair S. Sandalwood oil for the chemoprevention of skin cancer: Mechanistic insights, anti-inflammatory and in vivo anticancer potential. Current Pharmacology Reports. Springer Switzerland. 2019; 5(5): 345-358. 
9. Mishra A, Kataria I, Nair S. Pharmacokinetics and systems pharmacology of anti-CD47 macrophage immune checkpoint inhibitor Hu5F9-G4. Current Pharmacogenomics and Personalized Medicine. Bentham. 2019; 17(1): 14-24. 

• Synthesis and in vitro Cytotoxicity Studies of Certain Novel Heterocycle Derived from Bis 1, 2, 4-triazoles and their DNA damage studies. Medicinal Chemistry (Bentham Publishers) In Press.
• Chemosensitizing acridones: In vitro calmodulin dependent cAMP Phosphodiesterase inhibition, docking, pharmacophore modeling and 3D QSAR studies. Journal of Molecular Graphics and Modelling, Vol. 40, 2013, 116-124.
• Identification and synthesis of newer fluorescent probes and their usage as nanoparticle contrast agents in detecting cancer.  Current Pharmaceutical Design, Vol 19, 2013, 4622-4640.
• Synthesis and structure activity relationship studies of anti-calmodulin flouro acridone derivatives as cytotoxic agents effective in sensitive and resistant cancer cell lines and their mechanistic studies. European Journal of Pharmaceutical Sciences. Vol 43, 4, 2011 217-224.
• In vitro cytotoxicity and cell cycle analysis of two novel bis-1, 2, 4-triazole derivatives: 1,4-bis[5-(5-mercapto-1,3,4-oxadiazol-2-yl-methyl)-thio-4-(p-tolyl)-1,2,4-triazol-3-yl] butane (MNP-14) and 1,4-bis[5-(carbethoxy-methyl)-thio-4-(p-ethoxy phenyl)-1,2,4-triazol-3-yl]-butane (MNP-16). Nucleotides, Nucleosides and Nucleic acids, 30, 873–885, 2011.
• Synthesis chemical characterization of novel 1, 3-dimethyl acridones as cytotoxic agents effective in sensitive and their DNA binding studies. Medicinal Chemistry Research 19, 2010, 674-689.
• Synthesis and cytotoxicity studies of 1, 4-bis (4-substituted- 5-mercapto-1, 2, 4-triazol-3-yl) butanes and their in vitro antimicrobial studies. Medicinal Chemistry Research. In Press.
• Synthesis and cytotoxicity studies of bis-1, 3, 4-oxadiazoles and bis-pyrazoles derived from 1, 4-bis [5-thio-4-substituted-1, 2, 4-triazol-3-yl]-butane and their mechanistic studies. Archiv Der Pharmazie, 2010, 1-7.
• Current overview on the usage of Poly (ADP-ribose) polymerase (PARP) inhibitors in treating cancer. Clinical Cancer Drugs, 2014

• Parkar N, Veeranjaneyulu A. Amelioration of diabetic nephropathy by orange peel extract in rats. Natural Product Research. 2014 Aug 7:1-4. 
• Parkar N, Veeranjaneyulu A. Nobiletin Ameliorates Streptozotocin Induced Diabetic Retinopathy in Experimental Rats. Discovery Phytomedicine. 2014; 1: 3-7.
• Parkar N, Veeranjaneyulu A. Effect of Nobiletin on Diabetic Neuropathy in Experimental Rats. Austin J Pharmacol Ther. 2014; 2 (5).2
• Nishad Kadiri, Veeranjaneyulu A. (2012) Amelioration of cardiomyopathy in streptozotocin induced diabetic rats by long term administration of orange peel extract. Ind J Pharmacol 44, S81. (Abstract)
• Nishad Kadiri, Bhatt LK, Veeranjaneyulu A. (2010) Antidiabetic activity of aqueous root extract of Cocos nucifera in streptozotocin diabetic rats. Ind J Pharmacol. 42 (Supp 2): S215. (Abstract)

• Self Nan precipitating preconcentrate of tamoxifen Citrate for enhanced bioavailability; International Journal of Pharmaceutics, 2012, 429, (1–2), 104-112.
• Nanodrug Delivery in Reversing Multidrug Resistance in Cancer Cells. Frontiers in Pharmacology (Anti-Cancer Drugs), 2014:5(159), 1-22